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A B S T R A C T
Decades of research have underscored the importance of cyclic nucleotide signaling in memory formation and
synaptic plasticity. In recent years, several new genetic techniques have expanded the neuroscience toolbox,
allowing researchers to measure and modulate cyclic nucleotide gradients with high spatiotemporal resolution.
Here, we will provide an overview of studies using genetic approaches to interrogate the role cyclic nucleotide
signaling plays in hippocampus-dependent memory processes and synaptic plasticity. Particular attention is
given to genetic techniques that measure real-time changes in cyclic nucleotide levels as well as newly-devel-
oped genetic strategies to transiently manipulate cyclic nucleotide signaling in a subcellular compartment-
specific manner with high temporal resolution.
1. Introduction
1.1. Memory types, systems and processes
Memory is the process of acquiring, retaining and reconstructing
information over time (Kandel et al., 2014; McGaugh, 2000). Much has
been learned over the last two centuries regarding the fact that there
are different types of memory, each with distinguishable anatomical
circuits and molecular mechanisms. A general distinction can be made
between short-term memory, intermediate memory, long-term memory,
and working memory (Bear et al., 2007). Working memory is the in-
formation we can readily work with (Baddeley, 1992; Goldman-Rakic,
1995). Short-term memory is information that is held by the brain on a
temporary basis, lasting in the order of seconds to hours, and relies on
changes in intracellular signaling cascades (Manohar et al., 2017). In-
termediate memory encompasses the transition from short-term to
long-term memory that occurs within the first several hours following
the acquisition of new information (Sutton and Carew, 2002). Inter-
mediate memory relies not only on changes in intracellular signaling
but also de novo protein synthesis. Long-term memory, on the other
hand, is the information that is stored by the brain over a much longer
period, easily lasting days to years, and relies on changes in in-
tracellular signaling, de novo transcription, and de novo translation
(Jarome and Helmstetter, 2014). In the current review, we will focus on
long-term memory.
Long-term memory is divided into declarative versus non-declarative
memory systems (a.k.a. explicit versus implicitmemory systems) (Kandel
et al., 2014). Declarative memory mainly requires the hippocampus and
medial temporal lobe for its proper functioning; whereas, non-de-
clarative memory recruits brain areas such as the striatum and cere-
bellum. The declarative memory system includes episodic memories of
autobiographical life experiences and semantic memories of facts. The
non-declarative memory system encompasses procedural memories of
skills, associative memories of conditioning, non-associative memories of
habituation and adaptation), and priming. This review primarily focuses
on hippocampus-dependent declarative memory processes.
Memory formation involves acquisition, consolidation and retrieval
(Fig. 1) (Abel and Lattal, 2001). In the case of acquiring hippocampus-
dependent memories, attention is required to transfer sensory in-
formation to short-term memory or working memory (Abel and Lattal,
2001). For these short-term memories to be stored long term, they must
undergo consolidation. It is suggested there are three stages of con-
solidation, early consolidation resulting in intermediate memory, late
consolidation resulting in recent long-term memory, and systems con-
solidation resulting in remote long-term memory (Frankland and
Bontempi, 2005; Kesner and Hopkins, 2006; McGaugh, 2000). As noted
above, short-term hippocampus-dependent memory is encoded by
transient changes in neuronal transmission within the hippocampus
that require neither gene expression nor protein synthesis. In contrast,
intermediate memory and recent long-term hippocampus-dependent
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memory storage are maintained by stable neuronal changes that are
dependent on protein synthesis within the hippocampus (e.g., Heckman
et al., 2018; Izquierdo et al., 2002). These changes in synaptic strength
within the hippocampus are referred to as cellular consolidation or sy-
naptic consolidation. As these hippocampus-dependent recent long-term
memories (engrams) mature over the course of many weeks, they be-
come less dependent on the hippocampus and more dependent on other
brain regions like the cortex, with the resultant memories referred to as
remote long-term memories (Frankland and Bontempi, 2005). The
Standard Theory of Systems Consolidation suggest the hippocampus
“replays” the memory to other brain regions in order to promote waves
of cellular/synaptic consolidation therein, with the hippocampal trace
ultimately erased or silenced (Frankland and Bontempi, 2005; Kitamura
et al., 2017; Klinzing et al., 2019). That said, recent findings may
challenge this theory (Pilarzyk et al., 2019). Memory retrieval is the
process of accessing this stored information and bringing it back into
short-term or working memory. During retrieval, information can be
updated/altered and subsequently reconsolidated (Abel and Lattal,
2001; Phelps and Hofmann, 2019). In this review, we will focus on
cellular/synaptic consolidation of episodic memories in the hippo-
campus.
1.2. The hippocampus
The hippocampus is regarded as a central structure for episodic
learning and memory processes. It is a bilateral structure located in the
medial temporal lobe, adjacent to the lateral ventricle. The hippo-
campus is surrounded by the entorhinal, perirhinal and para-
hippocampal cortices as well as the amygdala, which provide the hip-
pocampus with sensory information processed by higher cortical
association areas. The hippocampus consists of multiple subfields,
namely the dentate gyrus, cornu ammonis 1 (CA1), CA2, CA3 and CA4,
with CA1 further subdivided into proximal versus distal and superficial
versus deep layers. Across species, the hippocampus is not a singular
brain structure, but rather is specialized along its axis (dorsal-ventral in
rodents, posterior-anterior in primates) in terms of gene expression
gradients, inputs/outputs, and brain function (Fanselow and Dong,
2010; Strange et al., 2014). In rodents, both the dorsal and ventral part
play a role in various types of learning and memory. The dorsal hip-
pocampus is additionally involved in orientation of movement and
spatial navigation; whereas, the ventral hippocampus appears to be
involved in limbic functions, social behaviors, motivation, stress re-
sponses, as well as neuroendocrine and autonomic functions (Behrendt,
2011; Fanselow and Dong, 2010; Gruber et al., 2010; Marquis et al.,
2008; Roman and Soumireu-Mourat, 1988; Tseng et al., 2008). The
majority of studies to date have focused on the role of the dorsal hip-
pocampus in memory formation; however, an increasing number of
studies are now focusing on the ventral hippocampus. As such, we will
review studies focusing on both the dorsal and ventral hippocampus.
1.3. Cyclic nucleotides
Here, we focus on 3’,5’-cyclic nucleotides, namely ‘3’,5’-cyclic ade-
nosine monophosphate’ (cAMP) and ‘3’,5’-cyclic guanosine monopho-
sphate’ (cGMP). Intracellularly, cAMP and cGMP act as second mes-
sengers, relaying signals from receptors on the cell surface to
intracellular signaling cascades. Although the majority of studies ex-
amining the function of cyclic nucleotides focus on their role in in-
tracellular signaling, it is important to keep in mind they are also found
extracellularly where they serve a variety of important autocrine and
paracrine functions (Ricciarelli and Fedele, 2018). As thoroughly re-
viewed elsewhere (Gurney, 2019), there are strong genetic associations
between cyclic nucleotide signaling molecules and human cognitive
performance, particularly among the enzymes responsible for de-
grading cyclic nucleotides. As we review below, both cAMP and cGMP
appear to play an important role in hippocampal neuroplasticity and
memory formation.
Previous reviews have focused primarily on the pharmacological
manipulation of cyclic nucleotide signaling in the hippocampus (e.g.,
(Heckman et al., 2018; Hollas et al., 2019; Prickaerts et al., 2017;
Ricciarelli and Fedele, 2018), but here we will focus on studies utilizing
genetic approaches. The reason for this is two-fold. First, cyclic nu-
cleotide signaling is compartmentalized within discrete subcellular
domains, with each domain regulated by a unique pool of synthesizing
and degrading enzymes (Baillie et al., 2019). Although pharmacological
studies have added to our understanding of the role cyclic nucleotide
signaling plays in memory formation, they are limited in terms of
spatiotemporal resolution because the pharmacological tools available
today are not able to target the synthesizing and degrading enzymes in
an isoform-specific manner—thus, multiple subcellular compartments
of cyclic nucleotide signaling are modulated at once (Baillie et al.,
2019). The second reason for focusing on studies using genetic tech-
niques is that the neuroscience toolbox has significantly expanded in
recent years with several genetic techniques (Deisseroth, 2015;
Gorshkov and Zhang, 2014; Roth, 2016). These genetic techniques
enable the measurement of real-time changes in cyclic nucleotide levels
at the level of specific subcellular compartments, as opposed to mea-
suring global changes in cyclic nucleotides that accumulate over time at
the level of an entire brain region. They also enable the manipulation of
cyclic nucleotide signaling in a subcellular compartment-specific
manner. To provide a context for these genetic studies, we first offer an
overview of cyclic nucleotide signaling in the hippocampus, including
how cyclic nucleotides are generated by cyclases and hydrolyzed by
phosphodiesterases (PDE) within discrete subcellular domains as well
Fig. 1. Schematic classification of the hippocampal memory
system including its memory types (short-term memory, long-term
memory and working memory) and processes (acquisition, con-
solidation and retrieval) during synaptic consolidation. STM =
short-term memory; WM = working memory; IM = intermediate
memory; LTM = long-term memory (figure partially based on
Reneerkens et al., 2009).
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as how cyclic nucleotides regulate neurotransmitter release and neu-
roplasticity. Subsequently, we review studies using genetic techniques
to study the role of cyclic nucleotide signaling in memory formation,
both studies measuring real-time changes in cyclic nucleotide levels and
those manipulating signaling.
2. Molecular mechanisms of memory: a role for cyclic nucleotides
in the hippocampus
2.1. Production of cyclic nucleotides
cAMP. The second messenger cAMP is synthesized from ‘adenosine
triphosphate’ (ATP) by ‘adenylate cyclase’. Adenylate cyclases can be
divided into nine membrane-bound (or particulate) and one soluble
adenylate cyclases (AC1-AC9). The membrane-bound adenylate cy-
clases are generally stimulated by Gs and inhibited by Gi and can be
divided into four groups based primarily on their sensitivity and reg-
ulation by Ca2+ (Antoni et al., 1998; Paterson et al., 1995). Group I
adenylate cyclases contains AC1, AC3 and AC8, which are activated by
Ca2+, group II contains AC2, AC4 and AC7 which are Ca2+-insensitive,
and group III consists of AC5 and AC6 which are inhibited by Ca2+.
Group IV is the exception and only contains AC9, which is non-re-
sponsive to forskolin and inhibited by calcineurin (CaN). Soluble ade-
nylate cyclase is mainly located in the nucleus, mitochondria and
centrosome during cell division and is activated by bicarbonate. Thus,
roughly speaking, soluble adenylate cyclases respond to intrinsic cel-
lular signals, whereas membrane-bound adenylate cyclases respond to
extracellular signals (Zippin et al., 2003).
Expression of AC isoforms differs across hippocampal subfields and
subcellular compartments. AC1 and AC2 are expressed in area CA1 and
dentate gyrus, while AC8 is only expressed in CA1. In contrast, ex-
pression of AC5 and AC6 is largely restricted to the CA2 subregion. AC9
is the only isoform that is highly expressed in all three CA subregions
and in the dentate gyrus (Antoni et al., 1998). AC1 and AC8 not only
differ in terms of regional distribution, they also each display a unique
pattern of subcellular localization. Whereas AC1 is abundantly ex-
pressed in the postsynaptic density and extrasynaptic sites, AC8 is
mainly found in the presynaptic active zone and extrasynaptic fractions
(Best et al., 2008). Thus, targeting different AC isoforms will modulate
distinct subcellular domains within separable neural circuits, thereby
differentially affecting memory formation.
cGMP. cGMP is also synthesized by both particulate and soluble
cyclases that convert ‘guanosine triphosphate’ (GTP) into cGMP.
Particulate guanylate cyclases are transmembrane enzymes that are
activated by natriuretic peptides. In contrast to the particulate guany-
late cyclase, that serves as a receptor for atrial, B-type and C-type na-
triuretic peptides, soluble guanylate cyclase is a receptor for gaseous
ligands, especially nitrous oxide (NO) (Castro et al., 2006; Evgenov
et al., 2006). NO is produced following activation of nitric oxide syn-
thase (NOS) in response to increased Ca2+ (Murad et al., 1978). Soluble
guanylate cyclase is typically found as a heterodimer, consisting of a
larger α-subunit and a smaller haem-binding β-subunit, although it also
exists as a homodimer (Zabel et al., 1999). Four human soluble GC
subunits have been identified: α1, α2, β1 and β2. The α1/β1 and α2/β1
dimers (a.k.a. NO-GC1 and NO-GC2) are the most well-known, and
exhibit indistinguishable catalytic, regulatory and pharmacological
properties (Gibb et al., 2003; Russwurm et al., 1998).
The different human isoforms of soluble guanylate cyclase have
been known for some time, however, little is published about their
overall tissue distribution. In the hippocampus, NO-GCs are pre-
synaptically localized in the excitatory and inhibitory axon terminals
(Budworth et al., 1999; Burette et al., 2002; Peters et al., 2018;
Szabadits et al., 2011). NO-GC2 also appears to be expressed post-
synaptically via interactions with the PDZ domain-containing protein
‘PSD-95’ (Russwurm et al., 2001).
2.2. Breakdown of cyclic nucleotides
The compartmentalization of cyclic nucleotides is not only achieved
by the distinct localization of the cyclases that generate them, but also
by the differential anchoring of the various phosphodiesterase (PDE)
isoforms that regulate their degradation (Baillie et al., 2019; Beavo,
1995; Conti and Beavo, 2007; Keravis and Lugnier, 2012; Lugnier,
2006; Maurice et al., 2014; Menniti et al., 2006). This compartmenta-
lization of cyclic nucleotide signaling became apparent with the iden-
tification of A-kinase anchoring proteins (AKAPs) that tether PKA, PDEs
and other proteins (Buxton and Brunton, 1983; Esseltine and Scott,
2013). PDEs are grouped into 11 families based on homology of their
catalytic domains, with most families having more than one gene
(Bender and Beavo, 2006). In total, there are estimated to be over a
hundred specific human PDEs due to the fact that most genes encode
several different splice variants (i.e. isoforms), each discretely localized
to specific subcellular domains (Baillie et al., 2019; Houslay, 2010;
Keravis and Lugnier, 2012; Kokkonen and Kass, 2017; Mongillo et al.,
2004). Some PDEs specifically hydrolyze cAMP (PDE4, PDE7 and
PDE8), others specifically hydrolyze cGMP (PDE5, PDE6 and PDE9),
and the remaining families hydrolyze both cyclic nucleotides (PDE1,
PDE2, PDE3, PDE10 and PDE11)(Francis et al., 2011). Several PDE
families are allosterically modulated by cyclic nucleotides themselves
constituting a feedback or feedforward mechanism (Francis et al.,
2011). Specific inhibitors have been developed for every family of PDEs
(Heckman et al., 2018), with several reaching the clinic for diseases
such as erectile dysfunction, chronic obstructive pulmonary disease,
and heart disease (Baillie et al., 2019; Maurice et al., 2014). Driven by
these commercial successes, numerous PDE inhibitors have been in-
vestigated preclinically for memory-enhancing effects (Heckman et al.,
2015b, 2017), with several yielding promising early results in clinical
trials (Baillie et al., 2019; Heckman et al., 2018; Prickaerts et al., 2017;
Heckman et al., 2015a, 2016).
2.3. Downstream signaling
In order for a given signaling event to regulate a specific physiolo-
gical response, cyclic nucleotides must be regulated in a compartmen-
talized manner via signalosomes involving effector molecules (Conti
et al., 2014; Maurice et al., 2014). Cyclic AMP has four main in-
tracellular effectors, including ‘exchange protein directly activated by
cAMP’ (Epac; a guanine nucleotide exchange factor for small G proteins
such as Rap), PKA, cyclic nucleotide gated channels, and POPEYE-do-
main containing proteins (Baillie et al., 2019). Of these, Epac and PKA
have been most studied in the context of hippocampus-dependent
memory. The Epac family consists of two isoforms, ‘Epac1’ and ‘Epac2’.
The PKA family is comprised of four regulatory (RIα, RIβ, RIIα, RIIβ)
and three catalytic (Cα, Cβ, Cγ) subunits resulting in the R subunit-
based division of PKA into the ‘PKAI’ (consisting of RIα and RIβ dimers)
and ‘PKAII’ classes (consisting of RIIα and RIIβ dimers). Both Epac and
PKA can regulate multiple processes, ranging from receptor trafficking
(e.g., Song et al., 2013) to phosphorylation of the transcription factor
‘cAMP response element binding protein’ (CREB)(Abel and Nguyen,
2008; Pierre et al., 2009). Similarly, cGMP activates PKG, which exists
in two forms, the soluble ‘PKGI’ and the membrane-bound ‘PKGII’
(Hofmann, 2005). Like PKA, PKG can also induce CREB activation by
means of phosphorylation, thereby regulating transcription (Lu et al.,
1999) (Fig. 2). The phosphorylation of CREB ultimately initiates tran-
scription of a set of specific genes, including those encoding neuro-
transmitter receptors (e.g., ionotropic AMPA receptors (Song et al.,
2013) and growth factors (e.g., ‘brain-derived neurotrophic factor’
(BDNF) (Scott Bitner, 2012).
2.4. Regulation of neurotransmitter release
In addition to regulating postsynaptic signaling events downstream
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of G-protein-coupled receptors (GPCR), cAMP can also regulate events
presynaptically. Adenylate cyclase that is present in the presynaptic
terminal is activated by (Ca2+)/calmodulin-dependent protein kinase
(CaMKII). This, in turn, leads to increased cAMP synthesis and activa-
tion of PKA. PKA can then stimulate docking, priming, and fusion of
presynaptic vesicles to the membrane by phosphorylating syntaphilin
and SNAP-25, Rab3 interacting molecule (RIM) and snapin, and cy-
steine string protein (CSP), respectively (Leenders and Sheng, 2005).
Similarly, presynaptic production of cGMP can be stimulated by the
retrograde messenger NO and, thus, regulate phosphorylation events
via activation of PKG. Thus, both a presynaptic CaMKII/cAMP/PKA
cascade (Bayer and Schulman, 2019) and a presynaptic NO/cGMP/PKG
cascade can regulate the synthesis, metabolism and release of neuro-
transmitters, including glutamate and dopamine (Cheng et al., 2018a,b;
Imanishi et al., 1997; Nishi and Snyder, 2010; Ohi et al., 2019;
Rodriguez-Moreno and Sihra, 2013; Schoffelmeer et al., 1985;Arancio
et al., 1995; Sanchez et al., 2002; Wang et al., 2017a) (Fig. 2). Acqui-
sition processes, short-term memory and, possibly, long-term memory
may be related, in part, to changes in neurotransmitter release that are
orchestrated by these cyclic nucleotide signaling pathways (Akkerman
et al., 2014, 2015).
2.5. Regulation of neuroplasticity
Both the cAMP/PKA/CREB and the cGMP/PKG/CREB pathways are
implicated in long-term potentiation (LTP), a proposed neurophysio-
logical correlate of memory (Bliss and Collingridge, 1993; Frey et al.,
1993; Lu et al., 1999). LTP can be induced and measured both in vitro
and in vivo, when a moderately high frequency stimulation produces a
stable and lasting increase in synaptic responses (Bliss and Collingridge,
1993; Reymann and Frey, 2007). A distinction is made between two
different types of hippocampal LTP (Ricciarelli and Fedele, 2018).
Early-phase LTP (E-LTP) lasts less than three hours, while late-phase
LTP (L-LTP) lasts 3 h or longer. Furthermore, it has been suggested that
E-LTP resembles early consolidation processes, while L-LTP is involved
in late consolidation processes in long-term memory (Bollen et al.,
2015, 2014; Heckman et al., 2017). A presynaptic cGMP/PKG pathway
(Arancio et al., 1996) as well as postsynaptic cGMP/PKG pathway have
been implicated in E-LTP (Taqatqeh et al., 2009). In contrast, cAMP/
PKA signaling appears not to be involved in E-LTP (Abel et al., 1997;
Bollen et al., 2015, 2014). A postsynaptic cAMP/PKA/CREB pathway as
well a postsynaptic cGMP/PKG/CREB pathway are essential for L-LTP
(Abel et al., 1997; Impey et al., 1996)(Lu et al., 1999) (Fig. 2). Inter-
estingly, early phase cGMP/PKG signaling has been shown to require
late-phase cAMP/PKA-signaling in L-LTP and long-term memory
(Bollen et al., 2014), suggesting that crosstalk between these signaling
pathways exists (Fig. 2).
3. Optical biosensors for measuring real-time changes in cyclic
nucleotide levels
Changes in cyclic nucleotide levels are traditionally measured with
biochemical techniques like radiolabel- and immuno-assays, which can
give a relative estimation of the amount of cAMP or cGMP in cell ly-
sates. Drawbacks of these approaches include a requirement for large
amounts of cells/tissue and, more importantly, a lack of spatiotemporal
resolution for measuring real-time changes in cyclic nucleotide gra-
dients in living cells. The development of optical biosensors based on
Förster resonance energy transfer (FRET), bioluminescence resonance
energy transfer (BRET), or single fluorescent proteins significantly im-
proved our ability to measure and monitor cyclic nucleotide dynamics
(Sprenger and Nikolaev, 2013)(Fig. 3).
3.1. FRET-based biosensors for detecting cAMP







































syntaphilin / RIM /
SNAP-25 / snapin cGMP
Fig. 2. Schematic diagram of pre- and postsynaptic cellular processes related to
the second messengers cAMP and cGMP involved in neuroplasticity in the
hippocampus. Presynaptically, both the cAMP and cGMP cascades can facilitate
enhanced neurotransmitter release. Postsynaptically, both the cAMP/PKA and
cGMP/PKG cascades activate several effectors including the transcription factor
CREB. In turn, CREB initiates transcription of specific genes coding for multiple
effector molecules including neurotransmitter receptors such as the ionotropic
AMPA receptors, or growth factors as BDNF. Abbreviations: PDE = phospho-
diesterase; Ca2+ = calcium; CaMKII = calmodulin-dependent protein kinase 2;
NOS = nitric oxide synthase; NO = nitric oxide; pGC = particulate guanylate
cyclase; sGC = soluble guanylate cyclase; cGMP = cyclic guanosine mono-
phosphate; PKG = protein kinase G; tAC = transmembrane adenylate cyclase;
sAC = soluble adenylate cyclase; cAMP = cyclic adenosine monophosphate;
PKA = protein kinase A; Epac = Exchange protein activated by cAMP; NPs =
natriuretic peptides; Gs = stimulatory G protein; CREB = cAMP response
element binding protein; Cre = cAMP response elements.
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levels were based on cAMP itself and made use of the dissociation of the
catalytic and regulatory subunits of PKA upon cAMP binding. ‘FlCRhR’
(Fluorescein-labeled PKA Catalytic subunit and Rhodamine-labeled
Regulatory subunit) was the first cAMP biosensor and comprised a
fluorescein-tagged catalytic subunit and a rhodamine-labeled reg-
ulatory subunit. Binding of cAMP to the regulatory subunit caused its
dissociation from the catalytic subunit leading to a reduction in FRET
emission (Adams et al., 1991). A few years later, Zaccolo and colleagues
developed a genetically-encoded cAMP biosensor in which the catalytic
or the regulatory subunit of PKA were fused with a fluorescent probe
(Zaccolo et al., 2000). FlCRhR proved useful in unraveling cAMP sig-
naling dynamics and compartmentalization in rat cardiac myocytes
(Zaccolo and Pozzan, 2002) and provided information about the spatial
distribution of cAMP/PKA during stimulation of sensory neurons in
Aplysia (Bacskai et al., 1993). Unfortunately, the use of this tool was
limited because of the need for equal expression of both recombinant
subunits and the potential interference of endogenous PKA subunits.
Challenges of the PKA-based detectors were overcome by the de-
velopment of singled-chained Epac-based biosensors that took ad-
vantage of the fact that cAMP induces a conformational change in Epac
upon binding. Both Epac1 and Epac2 were fused with cyan-fluorescent
protein (CFP) at the N-terminus and yellow-fluorescent protein (YFP) at
the C-terminus. In absence of cAMP, Epac biosensors remain in the
“closed” state. Thus, laser stimulation of the CFP generates an emission
spectrum that is capable of stimulating the YFP. Upon cAMP binding,
however, Epac “opens up”. Thus, the CFP is no longer close enough to
stimulate the YFP, resulting in a decrease in this FRET emission
(DiPilato et al., 2004; Nikolaev et al., 2004; Ponsioen et al., 2004).
Next, this Epac1 biosensor was fused to the N-terminal domain of dif-
ferent PKA subunits resulting in PKA-RI- and PKA-RII-specific FRET
biosensors (Wachten et al., 2010). In rat myocytes, these PKA-RI and
PKA-RII biosensors revealed a microdomain-specific regulation of
cAMP levels mediated through specific PDEs (Stangherlin et al., 2011).
For instance, stimulation of the β-adrenoceptor generates a spatially-
restricted pool of cAMP that mainly activates PKA-RII and to lesser
extent PKA-RI. Subsequent cGMP production via stimulation of soluble
guanylate cyclase promotes activation of PDE2 that is in close proximity
to the PKA-RII pool and inhibition of PDE3 that resides close to PKA-RI,
thus, reversing the PKA-defined cAMP gradient (Stangherlin et al.,
2011). Additionally, Epac2 biosensors tagged to AC8 (Epac2AC8D416N)
helped to identify distinct pools of cAMP microdomains associated with
adenylate cyclase activity in pituitary cells (Wachten et al., 2010). In-
terestingly, the transgenic mouse line ‘GAG-Epac1-camps’ that ex-
presses an EPAC1 biosensor ubiquitously allows detection of cAMP
signaling in a more physiological context (Calebiro et al., 2009).
The most well-known EPAC-based probes are called ‘ICUE’ (in-
dicator of cAMP using EPAC). Three versions have been developed
(ICUE1-3), each containing progressively improved properties (e.g.,
increases in dynamic range) that facilitate subcellular targeting
(DiPilato et al., 2004; Liu et al., 2012; Marley et al., 2013). ICUE1
constructs that were modified for trafficking to the plasma membrane,
mitochondria, and nucleus of HEK-293 cells revealed the differential
dynamics and propagation of cAMP signaling that exist within these
subcellular compartments following adrenergic stimulation (DiPilato
et al., 2004). ICUE2 is a biosensor like ICUE1, that has a membrane- and
mitochondria-targeting sequence removed from the N-terminus of the
Epac1 sequence, thereby exhibiting improvement in localization com-
pared to ICUE1 (Violin et al., 2008). ICUE3 probes targeted to the
nucleus showed that the nuclear PKA holoenzyme promotes signaling in
response to activated soluble adenylate cyclase (Hotte et al., 2012).
Additionally, utilization of the ICUE3 probe revealed a novel role of the
actin binding protein ‘coronin 1’ in modulating synaptic plasticity and
neurobehavioral processes via potentiation of the cAMP/PKA pathway
(Jayachandran et al., 2014).
An alternative approach to detect cAMP signaling is via the ‘A-ki-
nase activity reporter’ (AKAR). This family of biosensors contains a PKA
substrate sequence and a phospho-binding domain sandwiched be-
tween 2 fluorescent proteins. Increased PKA activity leads to phos-
phorylation of the PKA substrate and subsequent binding to the
phospho-domain increasing FRET. Where most previous biosensor
Fig. 3. Design of cyclic nucleotide biosensors including the general design and examples discussed in the current review. ICUE3 (indicator of cAMP using EPAC
version 3) is an EPAC-based biosensor to measure changes in cAMP levels. It consists of an Epac1149–881 sensing unit, eCFP donor, and a cpV-L194 acceptor reporting
unit. When cAMP binds to this sensor, it switches from high to low fluorescence emission. AKAR4 belongs to the family of biosensors that contain a PKA substrate
sequence and a phospho-binding domain sandwiched between 2 fluorescent proteins (Cerulean donor and cpV-E172 acceptor) for measuring PKA activity. Increased
PKA activity leads to phosphorylation of the PKA substrate and subsequent binding to the phospho-domain increasing FRET. δ-FlincG is used to detect changes in
cGMP gradients and contains, in contrast to most other sensors, a truncated cGMP binding domain from PKGIα or PKGIβ flagged with a single circularly-permuted
enhanced GFP, which increases the fluorescence emitted upon binding of cGMP (based on Gorshkov and Zhang, 2014).
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studies were conducted in cell cultures with a focus on cardiac function,
the AKAR-based biosensors have also been used to detect real-time
changes in cAMP gradients in brain slices (e.g., Castro et al., 2014). For
example, biosensor imaging in mouse brain slices showed that cAMP/
PKA signaling differs between striatal and cortical neurons (Castro
et al., 2013). Striatal neurons exhibit faster and longer-lasting responses
to stimuli that elevate cAMP/PKA levels compared to cortical neurons
due to several parameters including enhanced PDE4 activity in the
cortex and stronger adenylate cyclase activation in the striatum (Castro
et al., 2013). Another example comes from Tang and colleagues who
used the ‘AKARet-cyto’ biosensor to image PKA activation in single
dendritic spines during structural LTP in hippocampal CA1 pyramidal
neurons, revealing that the activation of this kinase spreads widely with
length constants of more than 10 μm (Tang and Yasuda, 2017).
3.2. FRET-based biosensors for detecting cGMP
For the detection and measurement of real-time changes in cGMP
gradients, similar biosensors have been developed for cGMP. cGMP
biosensors have to be highly sensitive due to the low concentrations of
cGMP in neurons. This need for high sensitivity has proven challenging.
cGMP biosensors are based on the fusion of a cyclic nucleotide binding
domain derived from PKG or cGMP-specific PDEs between two fluor-
ophores. The first PKG-based biosensors were the cygnet (cyclic GMP
indicator using energy transfer) series of cGMP biosensors (Honda
et al., 2001). The first biosensor, called ‘Cygnet-1’, was comprised of a
truncated version of PKGIα flanked between CFP and YFP at the N-
terminus and C-terminus, respectively; whereas, Cygnet-2 was the
catalytically inactive variant of Cygnet-1 due to a PKG1α-T516A mu-
tation (Honda et al., 2001). With both Cygnet probes, binding of cGMP
leads to a decrease in FRET (Sato et al., 2000). Sato et al. also generated
a PKG1α-based probe called ‘CGY-Del1’ that responded to cGMP
binding with an increase in FRET (Sato et al., 2000). The Cygnet bio-
sensors have contributed to our understanding of the spatiotemporal
dynamics of cGMP in various cell types (Cawley et al., 2007; Mongillo
et al., 2006; Takimoto et al., 2005). Regarding neural systems, cygnet
biosensors have shown that basal cGMP concentrations in thalamic
neurons are mainly regulated by PDE2 activity, even though they ex-
press PDE1, PDE2, PDE9 and PDE10 as well (Gervasi et al., 2007).
Furthermore, cygnet was used in combination with an EPAC-based
sensor (EPAC-SH150) to show that cGMP signaling can reduce cAMP
signaling through activation of PDE2 in striatal medium spiny neurons
(Polito et al., 2013).
Although these first generation cGMP biosensors shed new light on
cGMP signaling in the nervous system, they were still characterized by a
low dynamic range and limited temporal resolution. As a result, three
shorter cGMP biosensors were developed containing a single cGMP-
binding domain from PKGIα (cGES-GKIB), the GAF domain from
PDE2A (cGES-DE2), or the GAF domain from PDE5A (cGES-DE5)
(Nikolaev et al., 2006). Binding of cGMP decreases the FRET signal in
case of the PKGIα-based biosensor, while the FRET signal increases in
the case of PDE-based biosensors. All three cGMP biosensors show
strong FRET responses, however cGES-DE5 clearly has the greater se-
lectivity of cGMP over cAMP and is therefore the preferred sensor for
neuronal (live-cell) tissue (Gorshkov and Zhang, 2014). Two versions of
the same cGMP biosensor were used for simultaneous imaging of both
cAMP and cGMP in the same cell by substituting CFP/YFP by a red
(Dimer2) and green (T-Sapphire) fluorescent protein (Niino et al.,
2009). This drastically increased the affinity making it potentially sui-
table for measuring low concentrations of cGMP. The fluorescent in-
dicators for cGMP (FlincGs) line of biosensors was also seen as an im-
provement. The FlincGs (α-FlincG, β-FlincG, and δ-FlincG) contain a
truncated cGMP binding domain from PKGIα or PKGIβ flagged with a
circularly-permuted enhanced GFP, which increases the fluorescence
emitted upon binding of cGMP (Nausch et al., 2008). Finally, a blue
single-color cGMP sensor called ‘Cygnus’ was developed containing the
GAF-A domain of PDE5 fused between a blue fluorescent donor and a
dark fluorescent acceptor, which was able to detect cGMP signaling in
rat hippocampal neurons (Niino et al., 2010). In addition, Russwurm
and colleagues generated the cGi-500, cGi-3000, and cGi-6000 cGMP
biosensors with faster kinetics and a wide range of affinities by using
the tandem CNBD domains of PKGIα as a sensing unit (Russwurm et al.,
2007). They started out with the indicator CFP-PKGIα79–336-YFP,
elongated the N- and C-termini, and subsequently screened the con-
structs based on their affinity for cGMP and FRET response.
Clearly, cyclic nucleotide FRET-based biosensors have been dra-
matically improved in recent years (for an elegant overview see
Gorshkov and Zhang, 2014). The use of first-generation cGMP bio-
sensors to study memory-related processes at a cellular level has been
particularly limited by the fact that cGMP levels are so much lower than
cAMP levels in neurons. That said, more recent technical advances have
further improved the sensitivity and increased the dynamic range of
both the cAMP and cGMP biosensors. As a result, we are now seeing the
first reports emerge examining striatal signaling and excitability as well
as hippocampal synaptic plasticity (Muntean et al., 2018). For instance,
Muntean et al. used a newly developed cAMP sensor called ‘TEpacVV’
(Klarenbeek et al., 2011), which was placed under control of a chicken-
actin-G promoter and preceded by a STOP cassette flanked by LoxP
sites. The latter enabled the researchers to conditionally express the
sensor in a Cre recombinase-dependent fashion in any brain region and
cell type of interest of the mutant mice. This sensor uses mTurquoise as
donor providing double quantum efficiency and only single-exponential
fluorescent decay when compared to CFP described above (Muntean
et al., 2018; Calamera et al., 2019). Tang and Yasuda (2017) recently
developed a novel sensor that measures PKA protein content with ex-
tremely high spatial resolution. More specifically, this sensor has suf-
ficient sensitivity to detect changes in PKA gradients in small neuronal
compartments such as dendritic spines, something that was not possible
with other sensors
3.3. BRET-based biosensors
BRET is another, more recent form of biosensor used for imaging
protein association inside living cells. In case of BRET, a bioluminescent
molecule acts as energy donor, while for FRET both the donor and
acceptor are fluorescent molecules. Biswas and colleagues (Biswas
et al., 2008) developed a cGMP BRET biosensor for cGMP based on the
FRET-based biosensor described above (Niino et al., 2009). This BRET
biosensor utilized the GAF domain of the cGMP-binding PDE5 and
enabled researchers to show that these GAF domains act as an in-
tracellular sink for cGMP molecules, and could be used to identify al-
losteric modulators that bind to the GAF domain of PDE5.
3.4. Single fluorescent protein-based indicators for cAMP
Single fluorescent protein (1-FP)-based indicators have also been
developed. In comparison to the FRET or BRET biosensors, these in-
dicators utilize the exchange of ionization states in the chromophore of
a single fluorescent protein. The rationale for using these single fluor-
escent proteins is that the fluorescent intensity heavily depends on the
direct environment of the protein. Any conformational change will lead
to a slight change in the environment resulting in altered fluorescent
intensity (Matsuda et al., 2017). Using this approach, Flamindo2
(Odaka et al., 2014) was generated by inserting the Epac1 cAMP
binding domain into the middle of the YFP variant, citrine. Flamindo2
was reported to exhibit an increased dynamic range that was capable of
detecting very strong artificially induced cAMP responses (e.g., in re-
sponse to, for instance, forskolin). Pink Flamindo27, a red color variant
of Flamindo2 consisting of mApple, allowed advanced applications,
including in vivo imaging and optogenetic manipulations (Harada et al.,
2017). The affinity of 1-FP-based indicators for cAMP can be increased
by replacing the low-affinity EPAC cAMP binding domain with that of
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the high-affinity PKA regulatory subunits cAMP binding domain (e.g.,
Harada et al., 2017). Thus, Ohta and colleagues increased affinity and
expanded the dynamic range of their red fluorescent cAMP 1-FP in-
dicator termed ‘R-FlincA’ by inserting an mApple variant,
cp146mApple, into the high-affinity cAMP-binding motif of the PKA
R1α subunit (Ohta et al., 2018).
3.5. Single fluorescent protein-based indicators for cGMP
A single fluorescent protein-based indicator has also been developed
for cGMP, called ‘Green cGull’ (Matsuda et al., 2017). Green cGull is
based on the cGMP-binding domain of PDE5 inserted in the vicinity of
the chromophore Citrine, a green fluorescent protein. Binding of cGMP
will result in a conformational change of the fluorescent protein leading
to an increase in fluorescent intensity.
4. Genetic approaches for manipulating cyclic nucleotide
signaling
Genetic approaches used to manipulate cyclic nucleotide signaling
for the study of memory have dramatically evolved over the course of
recent decades. The majority of studies have employed conventional
knockout mice (KOs) and/or transgenic mice expressing/over-
expressing a “normal” enzyme, dominant negative enzyme, or a mole-
cule designed to disrupt subcellular localization of an enzyme. More
recent studies, however, have used chemogenetic and optogenetic ap-
proaches to more precisely manipulate cyclic nucleotide signaling
within discrete cell populations and/or neural circuits. Although studies
using conventional KO mice suffer from several limitations (e.g., po-
tential for compensatory upregulation of other signaling molecules,
failure to target one specific protein isoform, etc.), they have advanced
our knowledge of how cyclic nucleotide signaling regulates learning
and memoryand synaptic plasticity. Here we review studies that have
genetically manipulated cyclases, PDEs, or cyclic nucleotide effector
molecules.
4.1. Genetic manipulation of adenylate cyclases
4.1.1. AC1 and AC8
The majority of studies targeting ACs have focused on AC1 and AC8.
Although a recent review suggests neither AC1 nor AC8 are genetically
associated with cognitive performance in humans generally speaking
(c.f., (Gurney, 2019)), functional studies suggest an important role for
these enzymes specifically in hippocampal plasticity and memory. Early
work showed that genetic mutation of AC1 impaired induction and
maintenance of mossy fiber LTP (dentate gyrus→CA3; Villacres et al.,
1998) as well as induction—but not maintenance—of long-lasting
Schaffer collateral LTP (CA3→CA1; Wu et al., 1995). In contrast, in-
duction and maintenance of early Schaffer collateral LTP and perforant
path LTP (entorhinal area→dentate gyrus) were unaffected by the loss
of AC1 signaling (Villacres et al., 1998). When AC1 was transgenically
overexpressed throughout the forebrain, Schaffer collateral LTP was
strengthened (i.e., an early LTP protocol was able to induce long-lasting
LTP; Wang et al., 2004), while long-term depression was impaired, and
synaptic depotentiation remained intact in this pathway (Wang et al.,
2004; Zhang and Wang, 2013). These selective effects of AC1 manip-
ulations on mossy fiber and Schaffer collateral LTP/LTD are consistent
with the fact that 1) the Ca2+-stimulated AC1 is expressed in the
dentate gyrus and CA3 pyramidal cells, 2) induction of mossy fiber and
long-lasting Schaffer collateral LTP require Ca2+ (Kumar, 2011; Yeckel
et al., 1999) and cAMP/PKA signaling (Villacres et al., 1998), and 3)
mossy fiber LTP can be induced by forskolin (Villacres et al., 1998).
AC8 knockout mice also show deficits in mossy fiber LTP, but not early
Schaffer collateral LTP (Wang et al., 2003). Interestingly, mossy fiber
LTP deficits caused by deletion of AC8 are equivalent to deficits caused
by deletion of AC1, and deletion of both AC1 and AC8 does not further
exacerbate these LTP deficits (Wang et al., 2003). In contrast, whereas
the loss of either AC1 or AC8 does not affect long-lasting Schaffer col-
lateral LTP, depletion of both does impair the maintenance thereof
(Wong et al., 1999; Zhang et al., 2001). Given that AC8 deletion did not
affect Schaffer collateral LTP, it is surprising that transgenic restoration
of only AC8 throughout the forebrain was sufficient to rescue the
Schaffer collateral LTP deficits that were observed in the double
knockout (Wieczorek et al., 2012). Depletion of both AC1 and AC8 also
impairs long-term depression and synaptic de-potentiation (i.e., the
reversal of LTP) in this pathway (Wong et al., 1999; Zhang et al., 2011).
Together, these findings suggest that both AC1 and AC8 are important
for bidirectional synaptic plasticity. The fact that the effects of AC8
deletion plus AC1 loss of function are non-additive in some instances
(e.g., impairing mossy fiber LTP), yet synergistically interact in other
instances (e.g., impairing maintenance of Schaffer collateral LTP), may
be explained in part by the differential distribution of these two Ca2+-
stimulated adenylate cyclases across hippocampal subregions (Conti
et al., 2007).
AC1 and AC8 are also critical for formation and retrieval of hip-
pocampus-dependent memories. Mutation of AC1, but not AC8, impairs
memory retrieval in the visible and hidden platform water mazes (Wu
et al., 1995; Zhang et al., 2008b). Loss of both AC1 and AC8 function
also impairs memory in the hidden platform water maze, as it does the
ability to suppress previous memories of platform locations and form
memories for new locations (i.e., reversal learning; Zhang et al., 2011).
In contrast, overexpression of AC1 throughout the forebrain improves
the rate at which young adult mice acquire intial hidden platform lo-
cations as well as their reversal learning performance (Zhang and
Wang, 2013), but does not affect their long-term memory for the intial
platform location (Garelick et al., 2009). Interestingly, this type of
spatial memory is actually impaired by AC1 overexpression in old mice
(Garlick et al., 2009). Long-term social recognition memory is also
differentially affected by AC1 overexpression depending on the age of
the mice. Whereas young adult mice show stronger long-term memory
in response to AC1 overexpression, old mice show no effect (Garelick
et al., 2009). The fact that AC1 overexpression does not improve
memory in aged mice may appear counterintuitive considering the fact
that AC1 activity is downregulated with age in the hippocampus
(Garelick et al., 2009). That said, this downregulation may reflect a
compensatory protective mechanism in response to changes elsewhere
in the signal transduction cascade. Indeed, basal cAMP levels are not
thought to change with age in the hippocampus as they do in other
brain regions like prefrontal cortex (c.f., (Kelly, 2018a)). Alternatively,
the lack of positive effect in these hippocampus-dependent tasks may be
related to a deleterious influence of AC1 overexpression outside of the
hippocampus, particularly in the prefrontal cortex where cAMP levels
and PKA activity are already increased with age due to a down-
regulation of PDE4 (Arnsten et al., 2005; Ramos et al., 2003). Together,
these findings suggest that the role of cyclic nucleotide signaling in
hippocampus-dependent memory may evolve across the lifespan.
AC1 and AC8 affect other types of hippocampus-dependent mem-
ories as well. Mutation of either AC1 or AC8 is not sufficient to impair
recent long-term memory in a standard paradigm for passive avoidance
nor contextual fear conditioning (Wong et al., 1999). That said, deletion
of both AC1 and AC8 does impair recent memory for standard passive
avoidance (Wong et al., 1999), and deletion of AC8 along impairs
memory in a modified passive avoidance paradigm that employs tem-
poral dissociation (Zhang et al., 2008). This pattern of behavioral
phenotypes is similar to that described above for LTP where deletion of
either AC1 or AC8 was sufficient to impair mossy fiber LTP but deletion
of both was required to impair both the induction and maintenance of
Schaffer collateral LTP. Also in parallel with the LTP findings described
above, overexpression of AC1 was able to convert a short-term memory
training protocol into a long-term object memory (Wang et al., 2004).
Although AC1 mutant mice exhibit normal recent long-term memory
for contextual fear memory, they demonstrate impaired remote long-
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term memory 11 weeks after training when compared to wild-type mice
(Shan et al., 2008). The timing of this remote memory deficit is ex-
pedited when both AC1 and AC8 function are lost, with deficits in
contextual fear conditioning observed even at 7–8 days after training
(Wong et al., 1999; Wieczorek et al., 2012). Further, double knockout
mice fail to show enrichment-induced increases in contextual fear
memory 7 days after training, as do wild-type mice (Wieczorek et al.,
2012). Consistent with these findings, transgenic mice overexpressing
AC1 show normal recent long-term memory for contextual fear con-
ditioning yet an enhanced remote long-term memory 22 weeks after
training (Shan et al., 2008). This enhanced remote LTM is associated
with an impaired ability to extinguish the memory as well as increased
ERK and CREB phosphorylation (Wang et al., 2004). Together, these
findings point towards an important role for AC1 and AC8 in the for-
mation and stabilization of hippocampus-dependent memories.
4.1.2. AC3
Limited evidence also implicates AC3, a Ca2+-inhibited AC, as
playing a role in hippocampus-dependent memory. AC3 exhibits a very
unique expression pattern, with a discrete enrichment in primary
neuronal cilia (Bishop et al., 2007; Wang et al., 2011). Although the
exact role that neuronal cilia play in neuroplasticity and memory for-
mation remains to be elucidated, it is hypothesized that cilia represent
receptor signaling platforms (Green and Mykytyn, 2014). Similar to the
AC8 knockout mice described above, AC3 knockout mice show normal
memory in a standard passive avoidance assay, impaired memory in a
temporally-dissociated passive avoidance paradigm, and impaired ob-
ject recognition memory (Wang et al., 2011; Wong et al., 2000; Zhang
et al., 2008). Although AC3 KO mice demonstrate normal memory for
contextual fear conditioning, they fail to extinguish the memory (Wang
et al., 2011). This finding stands in contrast to that reported for AC1
mutant mice, which show intact extinction of contextual fear con-
ditioning (Shan et al., 2008). Thus, AC1, AC3, and AC8 appear to have
overlapping, yet distinct, roles to play in neuronal plasticity and
memory formation.
4.1.3. AC6
AC6, another Ca2+-inhibited AC, may also contribute to hippo-
campal function. Perhaps counterintuitively, genetic deletion of AC6
increases expression and phosphorylation of CREB within hippocampal
neuron nuclear fractions as well as expression and phosphorylation of
the NMDA receptor subunit GluN2B in hippocampal neuron synapto-
somal fractions (Chang et al., 2016). Interestingly, the effect of AC6 on
CREB levels is independent of AC6 catalytic activity (Chang et al.,
2016), suggesting the loss of AC6 fundamentally alters protein-protein
binding interactions within a specific macromolecular complex. In
concert with these biochemical effects, AC6 knockout mice exhibited an
increased ratio of NMDAR-mediated vs. AMAPR-mediated EPSCs,
stronger NMDA-dependent Schaffer collateral LTD, enhanced spatial
learning and reversal learning (although equivalent short-term spatial
memory) in the MWM, and stronger short-term memory for contextual
fear (Chang et al., 2016).
Together, these data have greatly contributed to our understanding
of how adenylate cyclases regulate memory formation. That said, they
also underscore the importance of moving toward more regionally-se-
lective manipulations in future studies. This may be accomplished by
utilizing cell-type specific promoters in combination with brain-region
specific injections of viral constructs. Ideally, promotors should be se-
lected that preferentially target a specific hippocampal sub-region, as
different sub-regions may be active during specific types of memory
(spatial vs non-spatial) and memory processes (acquisition, consolida-
tion, retrieval) (Havekes et al., 2007).
4.2. Genetic manipulation of guanylate cyclases
Only a handful of studies have examined the role of either soluble or
particulate guanylate cyclases in hippocampal function using genetic
approaches. With regard to soluble guanylate cyclases, NO-GC1 and
NO-GC-2 have been most studies. Electrophysiological and immuno-
fluorescence analysis localized NO-GC1 to the presynaptic compart-
ment and NO-GC2 to the postsynaptic compartment of glutamatergic
neurons in the hippocampus (Neitz et al., 2011, 2014; Neitz et al.,
2015). Deletion of either NO-GC isoform completely abolished LTP in
the visual cortex and hippocampal CA1 synapses (Haghikia et al., 2007;
Taqatqeh et al., 2009). These LTP deficits may be related to the fact that
NO-GC1 regulates glutamate and GABA release within CA1, and NO-
GC2 increases postsynaptic responsiveness of glutamatergic neurons
(Neitz et al., 2011, 2014; Neitz et al., 2015). Unfortunately, to our
knowledge no studies have been published that examine hippocampus-
dependent behaviors in these mouse lines. The only behavioral study to
date suggests that a loss of NO-GC1 from spinal dorsal horn neurons
leads to reduced hypersensitivity in models of neuropathic, but not
inflammatory pain; whereas, the loss of NO-GC2 from these same
neurons leads to increased hypersensitivity in models of inflammatory
but not neuropathic pain (Petersen et al., 2019). Although studies that
genetically manipulate guanylate cyclase are sparse, results to date
indicate an important role for soluble guanylate cyclases in neuro-
plasticity. These findings also underscore the importance for targeting
manipulations in a region, cell-type, and even subcellular compart-
ment-specific manner.
Only one study to date has examined the role of particulate guanylyl
cyclases in hippocampal function. Genetic deletion of GC-C impaired
short-term memory for novel object recognition, but recent long-term
memory for contextual fear conditioning was normal as was spatial
learning, spatial memory, and reversal learning in the MWM (Mann
et al., 2019). Consistent with this display of intact hippocampus-de-
pendent memory, serotonin and norepinephrine levels were unchanged
in GC-C knockout mice relative to wild-type mice (Mann et al., 2019).
Together, these data argue against a pervasive role of GC-C in hippo-
campal function.
4.3. Genetic manipulation of phosphodiesterases
4.3.1. Phosphodiesterase 1
PDE1 is a Ca2+-dependent, dual substrate cyclic nucleotide PDE and
this family of enzymes includes three genes PDE1A, PDE1B and PDE1C
(Beavo, 1995; Wennogle et al., 2017). PDE1C in particular has been
genetically associated with cognitive performance in humans (c.f.,
(Gurney, 2019)), and a balanced de novo inversion disrupting PDE1C
has been associated with developmental delay (Gamage et al., 2013).
Tools for genetically manipulating PDE1A, PDE1B, and PDE1C exist
(e.g., Cygnar and Zhao, 2009; Wang et al., 2017b; Ye et al., 2016);
however, only those targeting PDE1B have been used in the study of
hippocampal function. In both the passive avoidance and conditioned
avoidance tests, PDE1B knockout mice performed similarly to wild-type
mice (Siuciak et al., 2007b). In contrast, homozygous PDE1B (-/-) and
heterozygous PDE1B (+/-) knockout mice demonstrated spatial
learning and memory deficits in the hidden platform Morris water maze
(MWM) task when trained and tested as adolescents (postnatal day 50;
Reed et al., 2002). When tested as adults (postnatal day 85), however,
PDE1B homozygous KO mice showed intact spatial learning and
memory but impaired reversal learning in the MWM (Ehrman et al.,
2006). Surprisingly, viral knockdown of PDE1B in young adult mice
(3–6 months old) that was restricted to the CA fields of hippocampus
actually enhanced contextual fear conditioning memory and spatial
memory in the Barnes maze without effecting non-cognitive behaviors
(McQuown et al., 2019). Thus, local deletion in the hippocampus im-
proved memory function; whereas, general knockdown of the same
gene across brain regions impaired memory processes. PDE1B is known
to be expressed in cortical (Pekcec et al., 2018) and striatal (Nishi and
Snyder, 2010) neurons where it is tightly linked to dopamine receptor
function. Effects of PDE1B deletion on striatal functions, such as
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locomotion and reward processing, may partly explain the discrepancy
between localized versus global manipulations of PDE1B signaling
when considering hippocampal output.
4.3.2. Phosphodiesterase 4
The PDE4 family is cAMP-specific and encoded by 4 different genes,
PDE4A, PDE4B, PDE4C and PDE4D (Beavo, 1995; Houslay and Adams,
2003; O’Donnell and Zhang, 2004; Prickaerts et al., 2017). Only
PDE4A, PDE4B and PDE4D are expressed in the rodent and human
brain (Kelly et al., 2014; Lakics et al., 2010). Although multiple studies
have genetically associated PDE4B and PDE4D with human cognitive
performance in general (c.f., (Gurney, 2019) or mental disorders asso-
ciated with wide-ranging cognitive impairments (e.g., (Fatemi et al.,
2008; Lee et al., 2012; Linglart et al., 2012; Lynch et al., 2013; Michot
et al., 2012; Millar et al., 2005)), evidence to date largely points to
PDE4A and PDE4D playing the largest role in specifically regulating
hippocampus-dependent memories.
4.3.2.1. PDE4A. PDE4A knockout mice have been extensively
characterized to date. Relative to wild-type mice, PDE4A knockout
mice exhibit improved passive avoidance memory yet normal object
recognition memory and spatial memory as assessed in the MWM
(Hansen et al., 2014). The selective effect on passive avoidance memory
may be related to the aversive nature of the stimuli employed in this
particular paradigm coupled with the fact that deletion of PDE4A
appears to be anxiogenic as measured by the elevated-plus maze, light-
dark transition, and novelty-suppressed feeding tests. As extensively
reviewed elsewhere (Baillie et al., 2019), each PDE(4) isoform is
anchored to a unique set of protein complexes through its N-terminal
domain thereby leading to targeted degradation of cAMP in specific
intracellular compartments. Isoform-specific mutant mice have not yet
been published; however, studies employing viral vector approaches
are now emerging. Using an adenoassociated virus (AAV) to selectively
overexpress the PDE4A5 isoform, Havekes and colleagues showed that
increasing protein levels of the PDE4A5 isoform specifically in mouse
hippocampal excitatory neurons impairs forskolin-induced
hippocampal L-LTP and attenuates hippocampus-dependent long-term
memory in the Object Location Memory (OLM) and contextual fear
conditioning tasks (Havekes et al., 2016a). Interestingly,
overexpression of PDE4A5 did not impact short-term memory or
anxiety-related behaviors. The latter observation indicates that the
PDE4A isoforms affecting memory function and anxiety-related
behaviors might be different. Alternatively, it may be that PDE4A5
expression in regions other than the hippocampus (e.g., the amygdala or
prefrontal cortex) regulates anxiety-related behaviors. Importantly,
viral expression of a truncated version of PDE4A5, which lacks the
unique N-terminal domain required to properly localize the enzyme,
did not affect long-term memory. Likewise, overexpression of the
PDE4A1 isoform, which targets a different subset of signalosomes,
leaves memory undisturbed. This finding underscores the notion that it
is PDE4A5 and its proper localization that acts as a molecular constraint
on hippocampal memory and synaptic plasticity.
4.3.2.2. PDE4B. In contrast to PDE4A, it appears only select pools of
PDE4B play a role in hippocampus-dependent memory. Several groups
report that mice lacking PDE4B show normal learning in the MWM,
standard passive avoidance task, and/or contextual fear conditioning
(Siuciak et al., 2008a; Zhang et al., 2008a;Rutten et al., 2011).
Surprisingly, PDE4B knockout mice show reduced sensorimotor
gating in the prepulse inhibition of acoustic startle (PPI) task relative
to wild-type mice (Siuciak et al., 2008a), despite the fact that global
inhibition of the PDE4 family using rolipram strongly increases PPI
(Kanes et al., 2007; Kelly et al., 2007; Siuciak et al., 2007a). Although
PDE4B KO mice exhibit normal tetanus-induced and theta burst-
induced long-lasting Schaffer collateral LTP, they show increased
basal synaptic transmission and enhanced Schaffer collateral LTD
(Rutten et al., 2011). This may explain why PDE4B mice are normal
during initial learning but are impaired on reversal learning in the
MWM (Rutten et al., 2011).
More recently, groups have adopted a dominant negative approach
to specifically interrogate the function of the PDE4B1 isoform. The
Bolger lab developed transgenic mice that expressed a PDE4B1-D564A
mutant that exhibited reduced catalytic activity (Campbell et al., 2017).
Expression of a dominant negative mutation such as this will compete
for binding with endogenously expressed PDE4B1, thus reducing
PDE4B1 activity within specific signalosomes. PDE4B1-D546A trans-
genic mice exhibited increased phosphorylation of CREB and ERK in the
hippocampus, enhanced basal synaptic transmission, paired-pulse fa-
cilitation, and long-lasting Schaffer collateral LTP, but normal memory
for contextual and cued fear conditioning (Campbell et al., 2017). In
contrast, the Rodefer lab developed a PDE4B1-Y358C mutation, which
models schizophrenia-associated mutations that prevent PDE4B from
binding to the hub protein disrupted in schizophrenia 1 (Millar et al.,
2005). PDE4B1-Y358C transgenic mice showed increased CREB phos-
phorylation along with improved spatial working memory in the Y-
maze, object location memory, social recognition memory, as well as
learning, reversal learning, and memory on the MWM (McGirr et al.,
2016). Surprisingly, however, these mice showed impaired contextual
and cued fear conditioning 7 days after training, which authors at-
tributed to increased hippocampal neurogenesis (McGirr et al., 2016).
These behavioral phenotypes are associated with enhanced forskolin-
stimulated and tetanic-stimulated Schaffer Collateral LTP, but impaired
depotentiation of this circuit (McGirr et al., 2016). Together, these data
suggest that any one PDE4B-containing macromolecular complex reg-
ulates only limited aspects of hippocampus-dependent plasticity and
behavior, and that one PDE4B complex might cancel out the effect of
another depending on what other signaling molecules are present at the
time.
PDE4D. The role PDE4D plays in hippocampus-dependent memory
and plasticity may not be as straight forward as that described above for
PDE4A. Deletion of PDE4D increases cell proliferation and phosphor-
ylation of CREB in the mouse hippocampus (Li et al., 2011). Conven-
tional PDE4D knockout mice showed enhanced LTP in area CA1 relative
to wild-type mice when a subthreshold tetanic stimulation or theta
burst protocol was employed, but equivalent LTP when a long-lasting
LTP induction protocol was used (Rutten et al., 2008). PDE4D knockout
mice also exhibited improved recent long-term memory on both the
radial arm maze and the MWM 24 h after training (Li et al., 2011), but
weaker recent long-term memory for contextual fear conditioning
(Rutten et al., 2008). This contextual fear conditioning phenotype in
the global knockout may reflect signaling changes outside of the hip-
pocampus (e.g., amygdala) because selective knockdown of PDE4D in
the hippocampus alone improved recent long-term memory for con-
textual fear conditioning and increased the number of training-induced
stubby spines in CA1 (Baumgartel et al., 2018). Thus, these data argue
that PDE4D within the hippocampus represents a negative regulator of
hippocampal plasticity and memory.
Region-specific manipulations suggest that it is the long forms of
PDE4D specifically—both within and outside of the hippocampus—that
are a molecular constraint for hippocampus-dependent memories.
Selective knock down of PDE4 long-forms (i.e., PDE4D4 and PDE4D5
but not PDE4D1/2 nor PDE4D3) within the dentate gyrus of the hip-
pocampus strengthened recent long-term memory in the radial arm
maze, MWM, and object recognition tests (Li et al., 2011) and reveresed
Aβ-42-induced memory impairments in the MWM and object recogni-
tion tasks (Zhang et al., 2014). Biochemical analyses showed that se-
lective knockdown of PDE4D long forms increased phosphorylation of
CREB and cell proliferation in the hippocampus as did the global
knockout of PDE4D (Li et al., 2011). Thus, PDE4D4 and PDE4D5 play
particularly critical roles as negative regulators of hippocampal neu-
roplasticity, cell proliferation, and memory formation.
Together, these data suggest that specific PDE4A and PDE4D
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isoforms may be particularly interesting therapeutic targets for the
treatment of memory dysfunctions. It is important to note, however,
that broad spectrum PDE4 inhibitors characterized to date are asso-
ciated with emetic and other gastrointestinal side effects, most likely
due to inhibition of PDE4 within the area postrema (for review, see
(Baillie et al., 2019)). From a therapeutic perspective, it would be
preferable to only target those splice variants that exhibit disease-re-
lated changes in function, and to only target those isoforms in relevant
brain regions. Thus, it might be possible to not only avoid emesis and
other GI-related side effects, but also triggering other cognitive deficits
(e.g., issues with attention or working memory). As discussed elsewhere
(Baillie et al., 2019), such brain-region specific targeting of therapeutics
may be on the horizon with emerging advances in drug delivery and
gene therapy methodologies.
4.3.3. Phosphodiesterase 8
The PDE8 family is also cAMP-specific and comprised of two genes,
PDE8A and PDE8B (Beavo, 1995). Where PDE8A expression is largely
restricted to white matter in the CNS, PDE8B can be found in gray
matter, including that of the dentate gyrus and CA1 region of hippo-
campus (Kelly et al., 2014). As described by Tsai and colleagues (Tsai
et al., 2012), genetic ablation of PDE8B enhances recent long-term
memory for contextual fear conditioning and MWM. Importantly,
memory for delayed cued fear conditioning remained intact in the
PDE8B KO mice, suggesting their contextual fear conditioning memory
enhancement reflects altered hippocampal function as opposed to a
change in the amygdala. As a result, inhibition of PDE8B might seem to
be an interesting therapeutic approach for improving memory function.
That said, PDE8B knockout mice also show higher levels of anxiety-
related behavior, possibly limiting the potential of PDE8B as a ther-
apeutic target (Tsai et al., 2012).
4.3.4. Phosphodiesterase 10
PDE10 is a dual substrate family encoded by one gene, i.e. PDE10A
(Beavo, 1995; Menniti et al., 2007). PDE10A is predominantly ex-
pressed in striatal medium spiny neurons and is therefore mainly in-
vestigated as a therapeutic target for corticostriatal disorders including
schizophrenia, Parkinson’s disease, and Huntington’s disease (Geerts
et al., 2017). Nevertheless, some studies have investigated whether its
pharmacological inhibition or genetic deletion could be beneficial in
the memory domain as it is also expressed at low levels in the adult
rodent hippocampus (although not the adult human hippocampus;
(Farmer et al., 2020)). PDE10A knockout mice on a DBA1LacJ back-
ground showed normal acquisition and memory in the MWM (Siuciak
et al., 2006). PDE10A KO mice on either a DBA1LacJ or C57BL/6 N also
showed learning deficits in a conditioned avoidance behavior (Siuciak
et al., 2006, 2008b). However, this is likely caused by the loss of
PDE10A from the striatum, as the striatum rather than the hippocampus
is required for acquisition and maintenance of conditioned avoidance
(Oleson and Cheer, 2013). Selective deletion of the PDE10A2 isoform,
the predominant isoform expressed in brain, did not affect contextual
fear conditioning memory but did increase sociability of male mice
(Sano et al., 2008). This effect may be related to hippocampal
PDE10A2, specifically, because increasing PDE10A expression in the
nervous system via knockdown of its cognate microRNA (Mir137) re-
duced sociability in mice while also impairing LTP, social recognition
memory, and MWM learning (Cheng et al., 2018a,b). That said, many
other targets both in and outside of the hippocampus are changed in
response to Mir137 knock down (e.g., the catalytic subunit of PKA)
(Cheng et al., 2018a,b). Together, these studies raise the possibility that
PDE10A may play a limited role in hippocampus-dependent memories
in rodents; however, hippocampus-specific manipulations of PDE10
signaling will be required to establish this firmly.
4.3.5. Phosphodiesterase 11
The PDE11 family of cyclic nucleotide PDEs is also a dual substrate
family hydrolyzing both cAMP and cGMP and is encoded by the
PDE11A gene (Beavo, 1995; Kelly, 2017). PDE11A contains four dif-
ferent isoforms (PDE11A1-4) of which PDE11A4 is highly expressed in
the ventral hippocampal formation (Kelly, 2015) and low levels are
noted in the dorsal hippocampus, spinal cord, and dorsal root ganglion
(Kelly, 2018b). Outside of the nervous system, PDE11A expression
appears to be sparse (Kelly, 2015). PDE11A4 is the only PDE whose
expression in the brain originates solely from the hippocampal forma-
tion (Kelly et al., 2014). This highly selective expression profile would
provide an ideal candidate for targeting hippocampal memory function,
as it would enable selective therapeutic targeting of the brain region of
interest while avoiding other brain regions or peripheral organs that
might lead to side effects. Deletion of PDE11A alters social interactions
as well as the formation of social memories (Hegde et al., 2016a, b;
Kelly et al., 2010). Relative to wild-type littermates, PDE11A knockout
mice exhibit normal short-term memory for social odor recognition and
social transmission of food preference, but showed impaired recent
long-term memory 24 h post training. Importantly, PDE11A knockout
mice showed normal long-term memory for non-social odor recognition
at the 24 h time point. Interestingly, however, PDE11A knockout mice
go on to show stronger remote long-term memory for social odor re-
cognition and social transmission of food preference 7 days after
training (Pilarzyk et al., 2019). This transient amnesia correlates with
changes in the overal activation and functional connectivity of hippo-
campal/parahippocampal brain regions and frontal cortical regions
(Pilarzyk et al., 2019). Importantly, viral restoration of PDE11A4 se-
lectively to ventral CA1 was sufficient to reverse the transient amnesia
for social memories that was observed in PDE11A KO mice, again
without affecting non-social memories.
The work described above again emphasizes the importance to
study subregion-specific modulation of cyclic nucleotide signaling as
social memories are strongly associated with area CA1. It also high-
lights the benefit of targeting specific PDE subtypes, isoforms, or
compartments. Indeed, genetic deletion of the PDE11A4 isoform pro-
vides the opportunity to distinguish between recent and remote long-
term memory consolidation, which has not been shown previously for
any other PDE family.
4.4. Genetic manipulation of protein kinase A
As a reminder, PKA is a heteroligomer composed of 2 regulatory
subunits and 2 catalytic subunits. The regulatory subunits bind cAMP to
activate the enzyme and anchoring proteins to properly localize the
enzyme to relevant signalosomes. Studies utilizing genetic manipula-
tions to study the role of PKA in hippocampal plasticity and memory
have targeted expression, catalytic activity, and protein-protein inter-
actions.
4.4.1. Regulatory subunits
Genetic manipulations of PKA regulatory subunits suggest a dif-
fering role for RIβ and RII subunits in hippocampal plasticity and
memory. Although RIβ knockout mice showed normal Schaffer col-
lateral LTP relative to wild-type mice, they failed to maintain LTD and
demonstrated attenuated depotentiation of this pathway (Brandon
et al., 1995). RIβ knockout mice also failed to develop performant path
LTD (Brandon et al., 1995), and both the induction and maintenance of
mossy fiber LTP are profoundly impaired in RIβ knockout mic (Huang
et al., 1995). The fact that RIβ knockout mice exhibited normal Schaffer
collateral LTP is consistent with the fact that RII subunits are thought to
be the primary means by which PKA participates in this form of plas-
ticity (Wong and Scott, 2004). Despite these strong effects on hippo-
campal plasticity, RIβ knockout mice showed normal hippocampal
learning and memory in contextual fear conditioning, the MWM, and
the Barnes maze (Huang et al., 1995). Although LTP/LTD are often
conceptualized as cellular models of learning and memory, this is not
the only report in which genetic manipulation of cyclic nucleotide
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signaling has contrary effects on plasticity and memory (e.g., over-
expression of either a normal or constitutively active Gαs strengthens
LTP yet impairs hippocampus-dependent memory (Bourtchouladze
et al., 2006; Kelly et al., 2007, 2009).
The physiological role of the RIα subunit was explored using a
dominant negative approach. R(AB) transgenic mice (Abel et al., 1997;
Isiegas et al., 2006) express a mutated form of the regulatory RIα
subunit that maintains its ability to bind catalytic subunits but is un-
responsive to cAMP. Expression of the R(AB) transgene was restricted to
excitatory forebrain neurons, including those in the hippocampus, by
driving expression via a CaMKII promotor. Transgenic expression of this
inhibitory isoform reduced hippocampal PKA activity (Abel et al., 1997;
Isiegas et al., 2006) and impaired long-lasting—but not early—Schaffer
collateral LTP induced by 4x100 Hz stimulation (Abel et al., 1997).
Consistent with this plasticity profile, R(AB) transgenic mice showed
normal spatial learning but impaired recent long-term memory on the
MWM, as well as normal short-term memory but impaired recent long-
term memory and facilitated extinction of contextual fear conditioning
(Abel et al., 1997; Isiegas et al., 2006). The fact that recent-long term
memory for cued fear conditioning remains intact in R(AB) transgenic
mice suggests the fear conditioning deficit noted above is related to
hippocampal pathophysiology as opposed to amygdala dysfunction
(Abel et al., 1997). Together, these data argue that RIα plays a critical
role in regulating the consolidation and maintenance of hippocampus-
dependent long-term memories and LTP.
Loss of the RIIβ subunit produces different phenotypes than those
noted above in RIβ knockout mice. The RIIβ subunit links PKA to
NMDA receptors at synaptic sites (Yang et al., 2009). Consistent with
this fact, RIIβ knockout mice show changes in NMDA receptor-depen-
dent forms of plasticity. From postnatal day 10–14, RIIβ knockout mice
exhibit deficits in NMDA receptor-dependent Schaffer collateral LTP,
but normal NMDA receptor-dependent LTD (Yang et al., 2009). In
contrast, from P21 to P28, RIIβ knockout mice show normal LTP but
deficient LTD. These findings indicate that distinct PKA isoforms sub-
serve differing forms of synaptic plasticity and the roles for these dis-
tinct PKA isoforms may evolve across the lifespan.
Anchoring, as opposed to expression, of regulatory subunits has also
been genetically manipulated to specifically interrogate the need to
properly anchor PKA within specific subcellular compartments. Ht31
transgenic mice express a peptide that includes the PKA binding domain
of AKAP-Lbc (Nie et al., 2007; Park et al., 2014). This peptide acts as a
negative sink in that binding of Ht31 to PKA prevents PKA from binding
other AKAPs. This displacement of PKA from relevant signalosomes
reduces phosphorylation of protein phosphatase I and the AMPA re-
ceptor subunit GluA1 (Kim et al., 2011; Nie et al., 2007). Within the
Schaffer collateral pathway, expression of Ht31 postsynaptically (i.e.,
only in CA1) or both presynaptically and postsynaptically (i.e., in both
CA3 and CA1) was not sufficient to affect basal synaptic transmission,
paired pulse facilitation, early LTP induced by tetanic stimulation, nor
LTD. In contrast, transgenic expression of Ht31 postsynaptically was
sufficient to impair long-lasting LTP induced by tetanic stimulation,
while transgenic expression of Ht31 both presynaptically and post-
synaptically was required to impair long-lasting LTP induced by theta
burst stimulation, long-lasting LTP induced by forskolin, as well as
synaptic tagging (Nie et al., 2007; Park et al., 2014). Similarly, dis-
ruption of PKA anchoring in CA1 alone was not sufficient to impair
recent long-term memory in the MWM nor contextual fear con-
ditioning; however, disruption of PKA anchoring in both CA3 and CA1
was sufficient to drive long-term memory deficits in these assays (Nie
et al., 2007; Park et al., 2014). PKA binding to gravin-α (a.k.a. AKAP12)
may be particularly important for hippocampal function. Conventional
gravin-α knockout mice show impairments in hippocampus-dependent
forms of learning (e.g. MWM, contextual fear conditioning, OLM) as
well as deficits in L-LTP (Havekes et al., 2012). That said, these mice
also show attenuated performance in the novel object recognition and
tone-cued fear conditioning task, suggesting deficits on “hippocampus-
dependent” tasks could be driven by altered signaling in the perirhinal
cortex and/or amygdala as opposed to the hippocampus. Biochemical
analyses indicated that gravin-mediated PKA signaling plays an essen-
tial role in the crosstalk between glutamatergic and noradrenergic
signaling pathways, consistent with the types of memory and LTP
deficits described above (Havekes et al., 2012). In contrast, knockin
mice harboring a mutation that prevented PKA from specifically
binding AKAP5 (also known as AKAP79/150) showed impaired
Schaffer collateral LTP and LTD; however, spatial learning and memory
in the MWM remained intact as did memory for novel object recogni-
tion (Sanderson et al., 2016; Weisenhaus et al., 2010). Altogether, these
data argue that the proper localization of PKA to specific AKAP com-
plexes, particularly those within CA3 presynaptic compartments, is
important for hippocampus-dependent memories and long-lasting
forms of LTP.
4.4.2. Catalytic subunits
One study reported effects of genetically deleting a PKA catalytic
subunit, specifically the Cβ1 subunit (Qi et al., 1996). Deletion of Cβ1
was not sufficient to change basal or cAMP-stimulated PKA activity,
possibly due to the fact that Cβ1 is responsible for only ∼10 % of total
PKA activity (Qi et al., 1996). This genetic manipulation was, however,
sufficient to alter hippocampal plasticity. Although paired pulse facil-
itation and early Schaffer collateral LTP remained intact, late LTP, LTD,
and depotentiation of this pathway were impaired in Cβ1 knockout
mice relative to wild-type mice (Qi et al., 1996).
Taken together, these data suggest PKA plays a critical role in the
consolidation of hippocampus-dependent memory and long-lasting
forms of plasticity. They also underscore the importance of taking into
account regional differences in the expression and manipulation of in-
dividual PKA subunits and binding partners, as there are clearly di-
verging phenotypes depending on the subunit and hippocampal sub-
field targeted/interrogated.
4.5. Genetic manipulation of exchange protein directly activated by cAMP
(EPAC)
As mentioned previously, Epac represents a family of cAMP-binding
effector proteins that regulate several intracellular pathways and sig-
naling processes (Cheng et al., 2008; de Rooij et al., 1998; Kawasaki
et al., 1998; Woolfrey et al., 2009), including neural stem/progenitor
cell proliferation in the hippocampus (Zhou et al., 2018). Epacs ex-
change guanine nucleotides on small G proteins, such as Rap. In so
doing, they can act as a molecular switch from cAMP to downstream
cGMP signaling pathwys that are critical for neurotransmitter release
(Gekel and Neher, 2008; Zhong and Zucker, 2005), integrin cell adhe-
sion (Enserink et al., 2004; Rangarajan et al., 2003), and gene expres-
sion (Sands et al., 2006, 2012). Early electrophysiological studies sug-
gested that deletion of either Epac1 or Epac2 was not sufficient to affect
LTP; however, deletion of both isoforms reduced glutamate release
from presynaptic terminals in CA1 and caused a profound deficit in
long-lasting LTP (Yang et al., 2012). Epac1/2 double knockout mice
also exhibited more severe deficits in granule cell LTP relative to single
knockout mice; however, no changes in LTD were noted in this study
(Yang et al., 2012). The effect of Epac deletion on granule cell LTP
appears to be driven by reduced glutamate release that is caused by an
increased open probably of inwardly rectifying potassium channels in
the dentate gyrus (Zhao et al., 2013). In a later study, mossy fiber LTP
and cAMP-mediated potentiation of transmitter release were found to
be reduced in Epac2 knockout mice relative to wild-type mice, due to
smaller active zones and fewer synaptic vesicles in the readily re-
leasable pool (Fernandes et al., 2015). In this later study, Epac2
knockout mice also demonstrated a slightly weaker induction of early
Schaffer collateral LTP and stronger LTD (Lee et al., 2015). These
electrophysiological changes do not appear to be related to gross
morphological changes in CA1 as ultrastructure in the single and double
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knockout mice appear normal (Yang et al., 2012).
In terms of behavior, early studies suggested that pharmacological
activation of Epac immediately after training was sufficient to
strengthen basal short-term and recent long-term memory for con-
textual fear conditioning (Kelly et al., 2009) and partially reverse long-
term memory deficits in contextual fear memory caused by depletion of
norepinephrine (Ouyang et al., 2008). A later study, however, sug-
gested that pharmacological activation of Epac was only able to im-
prove retrieval of a contextual fear conditioning memory, not its con-
solidation (Ostroveanu et al., 2010). The ability of the Epac agonist to
improve memory retrieval was also observed in a standard passive
avoidance paradigm (Ostroveanu et al., 2010). These pharmacological
effects are likely mediated via Epac2 specifically because knockdown of
this isoform in the hippocampus using an siRNA impaired retrieval of a
recent long-term memory 72 h after fear conditioniong and blocked the
ability of the Epac agonist to improve retrieval at this time point
(Ostroveanu et al., 2010). Interestingly, no effect of intrahippocampally
infusing the Epac agonist nor Epac2 siRNA was observed when the fear
memory was retrieved 14 days after training (Ostroveanu et al., 2010),
a time point at which fear conditioning memories begin to rely more on
the cortex and less on the hippocampus (Frankland and Bontempi,
2005). Epac2 global knockout mice also showed reduced recent long-
term memory for contextual and cued fear conditioning; however,
Epac1 knockout mice show no change in recent long-term memory for
contextual fear conditioning yet enhanced recent long-term memory for
cued fear conditioning (Zhou et al., 2016). A particularly strong role for
Epac in fear memories may be related to the fact that stress upregulates
expression of Epac1 and Epac2 in the hippocampus and deletion of
Epac2 heightens stress-induced serum corticosterone levels, at least in
females (Aesoy et al., 2018), or the fact that foot shocks are felt more
strongly by Epac2 knockout mice (Lee et al., 2015).
Studies of other types of hippocampus-dependent memories suggest
function of Epac1 may compensate for the loss of Epac2 (and vice versa)
in some instances. Epac2 knockout mice exhibit normal spatial learning
and recent long-term memory in the MWM, normal spatial working
memory in the Y-maze, and normal object location memory (Srivastava
et al., 2012)(Yang et al., 2012; Lee et al., 2015; Zhou et al., 2016).
Epac1 knockout mice also show normal spatial learning and memory in
the MWM (Yang et al., 2012). Deletion of both Epac1 and Epac2,
however, severely impairs spatial learning and recent long-term
memory in the MWM (Yang et al., 2012). Interestingly, the effect of
Epac1/2 deletion was blocked by knockdown of the microRNA miR-124
(Yang et al., 2012). Together, these studies suggest the Epacs play a
critical role in regulating hippocampal plasticity and memory, but it
will be important for future studies to take a more targeted approach in
manipulating these isoforms in a region-specific manner.
4.6. Genetic manipulation of protein kinase G
Both global knockouts and hippocampus-targeted knockout mice
have been used to probe PKG function in the context of hippocampal
function. Early Schaffer-collateral LTP is unaffected by global deletion
of PKGI, PKGII, or both isoforms (Kleppisch et al., 1999). That said,
deletion of these enzymes led to severe gastrointestinal and cardio-
vascular defects and a reduced lifespan (Kleppisch et al., 1999), the
influence of which may have obscured an accurate assessment of hip-
pocampal plasticity (Schlossman et al., 2005). As such, Kleppisch and
colleagues generated PKG-I conditional knockout mice (Kleppisch et al.,
2004). By crossing these conditional knockouts with a NEX-Cre driver
line, deletion of PKG-I was restricted to the CA fields of the hippo-
campus, thus avoiding effects on gastrointestinal and cardiovascular
function as well as life expectancy (Kleppisch et al., 2003). Early
Schaffer collateral LTP was normal in both adolescent and young adult
PKGI cKO mice (Kleppisch et al., 2003), supporting findings described
above in the global knockout. In contrast, long-lasting LTP induced by
repetitive theta-burst stimulation was impaired in the adult PKGI cKOs
relative to normal mice (Kleppisch et al., 2003). Specifically, PKGI cKOs
were able to achieve equivalent potentiation following the initial theta
burst stimulation, but failed to demonstrate an augmentation of that
potentiation with successive bouts of stimulation. Interestingly, this
heightened potentiation that comes with successive theta-burst stimu-
lations is protein-synthesis dependent in adults and does not appear to
occur in juvenile mice (Kleppisch et al., 2003). Given that juveniles lack
this protein-synthesis dependent form of LTP, it is no surprise then that
adolescent PKG-1 cKO mice did not differ from normal adolescent mice
(Kleppisch et al., 2003). Despite these effects on plasticity, the adult
PKGI cKOs showed normal acquisition, memory and reversal learning
in a discriminatory water maze task and normal memory in contextual
and cued fear conditioning.
Although PKGII is much less abundantly expressed in the hippo-
campal formation than PKGI, it may play a more significant role in
hippocampal memory. PKGII conventional knockout mice show sig-
nificantly deficient spatial learning in the MWM and somewhat im-
paired short-term memory in the MWM (normal time in the target
quadrant but reduced platform crossings; Wincott et al., 2013). It is
unlikely that the increased latency to find the platform during MWM
training is related to locomotor issues, as PKGII KO mice show normal
locomotor activity in an open field and actually show stronger motor
coordination on the rotarod (Wincott et al., 2013). Interestingly, these
learning and memory deficits are associated with an upregulation of the
AMPA receptor subunit GluA1 in PKGII KO mice relative to wild-type
mice (Wincott et al., 2013). It remains to be determined, however,
whether this upregulation of GluA1 reflects a signaling deficit or an
attempt of the hippocampus to compensate for lost function.
Clearly more studies are needed to better understand the functional
role of PKG signaling in the hippocampus. More targeted genetic ma-
nipulations of these enzymes within the hippocampus, along with a
more thorough characterization of plasticity types (i.e., mossy fiber
LTP, performant path LTP, LTD, etc.) and hippocampus-dependent
memory types (e.g., social memories that are more dependent on the
ventral hippocampus), will improve our understanding of exactly where
PKG may influence hippocampal function. Initial studies suggest age
will be an important factor when probing the function of these en-
zymes, which may not be surprising given the number of age-related
changes that occur within the cyclic nucleotide signaling cascades
(Kelly, 2018a).
4.7. Chemogenetic manipulation of cyclic nucleotide signaling
Chemogenetic approaches employ naturally occurring or en-
gineered molecules that retain GPCR-like structure and function, but
are only activated by compounds/molecules that do not normally exist
in mammalian systems. Expression of these recombinant molecules in
the brain is often driven by a cell-type specific promoter (e.g., CamKII to
target pyramidal neurons) using either transgenic or viral technologies.
To modify signaling within one specific brain region, one can either 1)
express the transgene everywhere and then stereotaxically deliver the
activating compound or 2) virally deliver the transgene to a restricted
brain region and then deliver the activating compound either locally or,
in theory, systemically (since the compound should only act on the
recombinant receptor itself). Although spatial resolution is relatively
easy to achieve with chemogenetic approaches, the temporal precision
is limited by the pharmacokinetics of the compounds used to activate
them (Gomez et al., 2017; Guettier et al., 2009). As discussed in the
introduction, cAMP signaling is initiated following the activation of Gs-
coupled GPCRs and inhibited following the activation of Gi-coupled
GPCRs (Wang and Storm, 2003). Chemogenetic molecules are based on
these GPCR cascades but do not recognize any endogenous molecules in
mammalian systems either because they originate from a non-mam-
malian system or because they have been genetically engineered.
One of the first chemogenetic approaches was developed by the
Abel lab (Isiegas et al., 2008), and involved conditional expression of
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the Aplysia-specific octopamine Gs-coupled receptor. Expression of the
receptor was restricted to forebrain excitatory neurons of mice using
the CaMKII promoter. The octopamine receptor is activated by its
natural ligand octopamine, which does not naturally exist in mamma-
lian systems but can rapidly and transiently increase cAMP in mam-
malian cells when the octopamine receptor is recombinantly expressed
(Isiegas et al., 2008). As expected, administration of octopamine to the
transgenic mice led to a rapid elevation in hippocampal cAMP levels.
Although basal synaptic transmission remained unaffected, octopamine
administration to transgenic mice made an early LTP induction protocol
trigger long-lasting LTP within the Schaffer collateral pathway (Isiegas
et al., 2008). Octopamine administration 30 min before training, 3
h—but not immediately—after training, or 30 min prior to retrieval all
enhanced recent long-term memory (24 h after training) for contextual
fear conditioning in transgenic mice. Systemic injection 30 min before
training also improved short-term memory (1 h after training) for
contextual fear conditioning and recent long-term memory (24 h after
training) for object recognition memory. Together, these data suggest
that elevating cAMP during acquisition, later consolidation, or retrieval
is sufficient to strengthen hippocampus-dependent memory. Im-
portantly, the finding that cAMP signaling is particularly important for
late-stage consolidation and not that immediately following training
was later confirmed using pharmacological manipulation of cAMP (e.g.,
Bollen et al., 2014).
Later studies using chemogenetic approaches employed ‘Receptors
Activated Soley by a Synthetic Ligand’ (RASSLs) or ‘Designer Receptors
Exclusively Activated by Designer Drugs’ (DREADDs). Clozapine N-
oxide (CNO), a pharmacologically inert metabolite of the antipsychotic
drug clozapine, has been the most commonly used designer drug
(Armbruster et al., 2007; Roth, 2016). CNO has its limitations, however,
as a fraction of systemically-administered CNO is metabolized back to
clozapine (Jann et al., 1994; MacLaren et al., 2016), which more readily
crosses the blood brain barrier (Cremers et al., 2012; Hellman et al.,
2016), more potently binds DREADDs (Armbruster et al., 2007), and
has its own central effects (Mahler and Aston-Jones, 2018). Thus, more
recent efforts have focused on developing alternative ‘designer drugs’
for existing and newly engineered designer receptors (Roth, 2016).
The Gs-coupled DREADDs (GsD and rM3D) increase cAMP levels
when the activated Gα subunit stimulates adenylate cyclase, while the
Gi-coupled DREADDs (hM4Di and KORD) decrease cAMP levels when
the activated Gα subunit inhibits adenylate cyclase (Roth, 2016). Un-
fortunately, activation of a Gi-coupled DREADD can also activate
GIRKs, alter β-arrestin signaling and impact Ca2+ (Armbruster et al.,
2007; Rogan and Roth, 2011; Saloman et al., 2016). As such, it is not
possible to discern whether effects of Gi-coupled DREADDs on hippo-
campal plasticity and memory (e.g., Alexander et al., 2018; Jones et al.,
2018; Lopez et al., 2016; Nam et al., 2019; Ortiz et al., 2019; Park et al.,
2016; Tuscher et al., 2018; Varela et al., 2016; Zhu et al., 2014) are
mediated by reductions in cAMP signaling or effects on other down-
stream signaling pathways. Although several reports have used Gs-
coupled DREADDs to study the role of the striatum or other brain re-
gions in a variety of behaviors (e.g., (Oliver et al., 2019; Pleil et al.,
2015; Ferguson et al., 2013; Farrell et al., 2013; Brancaccio et al.,
2013), only one study has reported effects on a hippocampus-dependent
memory. In this one study, activating rM3D DREADDs selectively in the
hypothalamic hypocretin/orexin system, which is known to project to
the hippocampus, improved short-term spatial memory but not novel
object memory (Aitta-Aho et al., 2016).
Together, these findings provide proof of principal for utilizing
chemogenetic approaches to study the role of cyclic nucleotide sig-
naling in the context of hippocampal function. That said, these pow-
erful tools have clearly been underutilized in this realm. It will be of
interest to future studies to use these tools to study the role cAMP plays
within specific cell types within the hippocampus by using cell-type
specific promoters to drive their expression. It will also be highly in-
teresting to couple this technology with conditional expression systems
that enable the selective manipulation of cAMP signaling within one
specific hippocampal circuit at a time (e.g. ventral CA1 → to nucleus
accumbens). Although all DREADDs to date are based on GPCRs, it
would also be interesting to explore the possibility of engineering
particulate guanylate cyclase receptors into cGMP-regulating DREADDs
to expand the neuroscience toolbox even further. Even though che-
mogenetic studies are limited, the results to date support the notion that
acute increases in cAMP levels within hippocampal neurons, or neurons
that project to the hippocampus, facilitate hippocampal neuroplasticity
and memory.
4.8. Modulation of cyclic nucleotide signaling through optogenetics
Despite the fact that transgenic, viral and chemogenetic approaches
allow us to conditionally modulate cyclic nucleotide signaling in a cell
type-specific fashion, there are temporal limitations to these ap-
proaches with a resolution ranging from minutes to hours. Optogenetics
tools do not suffer this limitation. In the case of classical optogenetics,
neurons are genetically modified to express one of three classes of
microbial light-sensitive proteins called ‘opsins’, which, when activated
by light, cause neuronal excitation or inhibition. The first class, ‘bac-
teriorhodopsins’, pump protons out of the cell causing hyperpolariza-
tion when inserted into a neuron and subsequently lead to neuronal
inhibition. The second class, ‘halorhodopsins’, cause hyperpolarization
of neurons and neuronal inhibition by pumping negatively charged
chloride ions into the cell. Thirdly, ‘channelrhodopsins’ can either ex-
cite or inhibit neural systems when inserted into a neuron by allowing
positively charged ions to flow into the cell or by chloride conduction,
respectively (Boyden et al., 2005; Deisseroth, 2015). Next to these
classical membrane-spanning actuators, the optogenetic toolbox has
been expanded with soluble light-activated enzymes, photocontrol of
protein-protein interactions, and cryptochromes that mediate light-in-
duced protein oligomerization (Rost et al., 2017). The group of soluble
light-activated enzymes includes photoactivated cyclases that bind
flavin adenine dinucleotide (FAD) and engineered light-activated PDEs
that use biliverdin as a chromophore, both permitting optogenetic
control of cyclic nucleotide signaling (Rost et al., 2017).
Several adenylate cyclase optogenetic molecules have also been
developed. The first ‘photoactivated adenylate cyclase’ (PAC), named
‘euPAC’, was identified in Euglena gracilis in which it serves a role in
photoavoidance. This adenylate cyclase has a heterotetrameric struc-
ture consisting of two PACα and PACβ subunits that are activated by
blue light and four catalytic domains homologous to group III adenylate
cyclases (Iseki et al., 2002). The functional expression of PACα and
PACβ was verified in different systems including Xenopus laevis oocytes,
HEK293 cells, Aplysia and Drosophila melanogaster (Nagahama et al.,
2007; Schroder-Lang et al., 2007). Unfortunately, the large size and
high basal activity in the absence of light prevented the wide applica-
tion of euPAC in other organisms. Another PAC, named ‘BlaC’, was
engineered by the Gomelsky lab. The construct contained the blaC gene
encoding a group III adenylate cyclase isolated from Beggiatoa sp. and
one BLUF domain (sensors of blue-light using FAD), significantly de-
creasing size (Ryu et al., 2010). At approximately the same time, the lab
of Hegemann validated the efficacy of the same protein, which they
named ‘bPAC’ (Stierl et al., 2010). In Escherichia coli and Xenopus oo-
cytes, bPAC showed low cyclase activity in the absence of light that is
increased by 300-fold in the light. More importantly, the applicability
of bPAC was proven in rat cortical neurons (Stierl et al., 2010), Dro-
sophila nervous system (Efetova et al., 2012; Stierl et al., 2010) as well
as zebrafish (Brancaccio et al., 2013; De Marco et al., 2016; Gutierrez-
Triana et al., 2015). More recently a blue light-regulated adenylate
cyclase was identified in Microcoleus chthonoplastes, therefore termed
‘mPAC’. This enzyme contains a photoreceptive LOV domain and ex-
hibits higher constitutive activity in comparison to euPAC and BlaC/
bPAC, but also higher activity after blue light irradiation (Chen et al.,
2014; Raffelberg et al., 2013). Although exhibiting a promising
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dynamic range, extensive use of these PACs was restricted due to dis-
advantages including low tissue penetration and photooxidative da-
mage by the blue light (Hockberger et al., 1999).
To overcome these limitations, the Gomelsky lab engineered the
first synthetic PACs activated in the near-infrared window (NIRW) (Ryu
et al., 2014). Their ‘Ilac’ construct contains a photosensory module from
the Rhodobacter sphaeroides bacteriophytochrome DGC, BphG1 and a
type III adenylate cyclase domain from the Nostoc sp. CyaB1 protein.
The effectiveness of Ilac was validated in Caenorhabditis elegans in
which exposure of red light to cholinergic neurons resulted in elevation
of cAMP/PKA signaling and subsequent altered locomotor behavior
(Ryu et al., 2014). Recently, the same group engineered a successor,
designated ‘IlaM5’, which has several advantages over previous NIRW-
adenylate cyclases. For example, IlaM5 has significantly higher activity
at 37 °C, is better expressed in mammalian cells, and can mediate
NIRW-induced gene expression through activation of the cAMP
pathway in mammalian cells (Fomicheva et al., 2019). The IlaM5 gene
expressed from an AAV vector was delivered into the ventral basal
thalamus region of the mouse brain, resulting in the light-controlled
suppression of the cAMP-dependent spindle oscillations of the sleeping
brain (Fomicheva et al., 2019). Reversible spindle oscillation suppres-
sion was observed in sleeping mice exposed to NIRW light from an
external light source without the need for fiber optic cables (Fomicheva
et al., 2019). This ultimately confirms the robustness of principles of
homodimeric bacteriophytochrome engineering, supports the notion
that NIRW-adenylate cyclases are finally suitable for mammalian op-
togenetic applications, and that controlling brain activity via NIRW-
adenylate cyclases using transcranial irradiation is feasible. Moreover,
the generation of NIRW-activated adenylate cyclases provides the op-
portunity to combine optogenetics with imaging techniques for de-
tecting or manipulating cyclic nucleotide signaling. Together, it results
in extremely high spatial and temporal resolution without the need for
fiber optic cables or connectors attached to the head of the animal that
could interfere with normal behavior.
Photoactivated guanylate cycleases have also been developed. The
first photoactivated guanylate cyclases were engineered by inducing
multiple mutations in the Beggiatoa BlaC. The resulting triple mutant,
designated ‘BlgC’, was shown to exhibit guanylate cyclase activity in
vitro and significant increases in cGMP production in vivo after irra-
diation with blue light (Ryu et al., 2010). The first natural light-acti-
vated guanylate cyclase was identified in the fungus Blastocladiella
emersonii by the group of Gomes and named ‘BeGC1’ (Avelar et al.,
2015; Scheib et al., 2015). It consists of rhodopsin fused to the catalytic
domain of guanylate cyclase and is activated by green light. The effi-
cacy of the enzyme was confirmed in in vitro and in vivo assays including
HEK293 T cells, Xenopus oocytes, muscle cells of Caenorhabditis elegans,
mammalian ovary cells and cortical neurons (Gao et al., 2015; Scheib
et al., 2015). The Gomelsky lab also engineered a NIRW-activated
construct for the production of cGMP (Ryu and Gomelsky, 2014). The
chimeric construct was comprised of a bacteriophytochrome c-di-GMP
synthase (diguanylate cyclase, DGC) originating from the Rhodobacter
sphaeroides BphG1 protein and a constitutive c-di-GMP-specific PDE,
YhjH, from E. coli. DGC is not endogenously expressed in higher eu-
karyotes and has potential to regulate cGMP signaling in mammals (Ryu
and Gomelsky, 2014).
In addition to optogenetic manipulation of cyclic nucleotide pro-
duction by development of light-sensitive cyclases, similar attempts
have been made to optogenetically target the degradation of cyclic
nucleotides by the engineering of light-activated PDEs (LAPD). The first
LAPD was comprised of the photosensor module of Deinococcus radio-
durans bacterial phytochrome and the effector module of the human
PDE2A (Gasser et al., 2014). Since PDE2A is a dual-substrate PDE, the
photoactivated construct also has dual substrate specificity, and illu-
mination with red light enhances the hydrolysis of both cGMP and
cAMP by 4–6 fold. Moreover, exposure of LAPD to far-red light de-
creases its activity. LAPDs have shown to efficiently increase cyclic
nucleotide hydrolysis in eukaryotic cell cultures and zebrafish embryos
(Gasser et al., 2014). Two other groups isolated a similar dual substrate
enzyme with PDE activity from the choanoflagellate Salpingoeca rosetta
(Lamarche et al., 2017; Yoshida et al., 2017). The ‘Rh-PDE’ or
‘RhoPDE’, as it was named by the different groups, is a fusion of rho-
dopsin type I with PDE. Unfortunately, the enzyme displays only a
minimum amount of light-dependent PDE activity. It can again hy-
drolyze both cyclic nucleotides, but with higher selectivity for cGMP
over cAMP (Lamarche et al., 2017; Tian et al., 2018; Yoshida et al.,
2017). Crystallography of the isolated PDE domain of the enzyme
showed high resemblance in terms of sequence and structure to the
human PDE9 (Lamarche et al., 2017).
Modulation of cyclic nucleotide signaling through optogenetics is
currently the optimal technique in the genetic domain to achieve high
spatial and temporal resolution. The recent generation of NIRW-acti-
vated adenylate cyclases removes the need for fiber optic cables and
connectors, eliminating their interference with normal mammalian
behavior. This also provides the opportunity to combine optogenetics
with imaging techniques for detecting or manipulating cyclic nucleo-
tide signaling. Together, it results in extremely high spatial and tem-
poral resolution making the NIRW-activated cyclases very suitable to
study the spatial and temporal dynamics of cyclic nucleotide signaling
in vivo during neuroplasticity and memory formation. Such spatial and
temporal control may also lead to novel therapeutic inroads given that
optogenetic-based approaches are being tested in the clinic (Ye and
Fussenegger, 2018). For example, being able to activate or inhibit a
given PDE using a temporally and spatially restricted light emission
would enable a brain-region specific treatment of cyclic nucleotide
dysfunction, which is necessary when attempting to treat a disease
where cyclic nucleotide signaling is upregulated in one tissue yet
downregulated in others (e.g., aging; c.f., (Kelly, 2018a)). Spatially re-
stricting the PDE modulation would also avoid side-effects associated
with modifying PDE activity within a specific tissue (e.g., the gastro-
intestinal side effects caused by PDE4 inhibition in the area postrema).
5. Genetic manipulation of cyclic nucleotide signaling during
suboptimal memory formation caused by sleep deprivation
Previous work has shown that sleep deprivation impairs cAMP
signaling in the hippocampus leading to deficits in consolidation of
contextual fear conditioning memories (Graves et al., 2003; Vecsey
et al., 2009). First evidence for the involvement of cAMP in the negative
effect of sleep deprivation on memory function came from electro-
physiological studies using LTP (Vecsey et al., 2009). Sleep deprivation
specifically impaired forms of LTP that depend on the cAMP/PKA
pathway, like spaced 4-train LTP and theta burst-induced LTP (Vecsey
et al., 2009). When an AAV using the CaMKIIα promoter was used to
express the Gs-coupled octopamine receptor selectively in hippocampal
excitatory neurons, it was possible to produce transient increases in
cAMP levels via activation of the recombinant octopamine receptors.
Doing so during the course of sleep deprivation prevented the memory
consolidation deficits. These findings demonstrate that attenuated
cAMP signaling in hippocampal excitatory neurons is a critical com-
ponent underlying the memory deficits in hippocampus-dependent
learning tasks associated with sleep deprivation.
In two follow-up studies, Havekes and colleagues showed the above
sleep deprivation-induced deficits in LTP and memory were associated
with structural losses of dendritic spines in area CA1 (Havekes et al.,
2016b) and dentate gyrus (Raven et al., 2018) of dorsal hippocampus.
Sleep deprivation was found to increase activity of PDE4A5 thereby
upregulating activity of the actin-binding protein cofilin via disinhibi-
tion of the cAMP-PKA-LIMK pathway (Havekes et al., 2016b). Viral
expression of a dominant-negative, catalytically-inactive form of
PDE4A5 (referred to as PDE4A5catnull) in hippocampal neurons restored
cofilin signaling and prevented the behavioral impairments associated
with sleep loss. Importantly, the therapeutic effects of the PDE4A5catnull
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construct required its N-terminal domain, which is responsible for its
proper localization within PDE4A5-specific signalosomes. The latter
finding again highlights an essential role for the N-terminal domain in
targeting PDEs to specific cAMP-containing complexes critical for
memory and synaptic plasticity and emphasizes how region- and cell
type-specific manipulations of a specific PDE isoform can map out the
complete molecular machinery mediating the negative effect of sleep
deprivation on hippocampal plasticity and memory function.
6. Discussion & future perspectives
In the current review, we provided a detailed overview of studies
using genetic manipulation of cyclic nucleotide signaling to better
comprehend their function during hippocampal plasticity and memory
formation. The use of genetic approaches has revolutionized our un-
derstanding of the molecular mechanisms underlying memory storage.
Initially, these genetic approaches used conventional knockout strate-
gies in which genes were inactivated in all tissues throughout the life of
the organism. Although studies using these classical knockout strategies
have greatly advanced our knowledge of the function of specific genes
related to cyclic nucleotide signaling, their use in behavioral and
electrophysiological experiments is complicated due to interpretational
issues related to developmental alterations, compensation by other
biochemical pathways, and lethality.
As a result, new transgenic and conditional methods were devel-
oped, each, in their own way, trying to increase spatial resolution.
These novel methods have been extensively used over the years in all
domains of neuroscience and include the use of the CaMKII promoter to
drive gene expression selectively in postnatal neurons in the forebrain
(Abel et al., 1997; Mayford et al., 1995), the Cre/LoxP system to se-
lectively delete genes in subsets of neurons (Tsien et al., 1996a, b), and
the conditional tetracycline transactivator system (tTA) (Mansuy et al.,
1998; Mayford et al., 1996) to turn gene expression on or off. Despite
the fact that these systems successfully increased the spatial resolution
with which genes can be manipulated compared to conventional gene
knockouts, they are still characterized by a relatively poor temporal
resolution (Mansuy et al., 1998). Further, using Cre recombinase, genes
are irreversibly deleted over a time course of days to weeks even when
conditional forms of Cre recombinase are used (Feil et al., 1996;
Ratnacaram et al., 2008).
Cyclic nucleotides as well as their effector molecules are activated
within a time course of minutes to hours during memory storage (Abel
and Lattal, 2001). For instance, both cGMP and cAMP have their spe-
cific temporal windows during which they mediate early and late
consolidation, respectively (Bollen et al., 2014). This suggests that
distinct biochemical processes underlie each of the different memory
processes (Abel and Lattal, 2001). Genetic tools have been developed
that enable the rapid, reversible regulation of neuronal excitability
using optogenetic techniques based on the microbial opsins, channelr-
hodopsin-2 and halorhodopsin (Zhang et al., 2007). Although these
early optogenetic tools provided high temporal resolution, they do not
target cyclic nucleotide signaling pathways, but rather alter neuronal
excitability. Thus, the development of genetic systems to manipulate
intracellular signaling pathways, while maintaining high temporal and
spatial resolution, remained. Since the classical membrane-spanning
actuators, the optogenetic toolbox has been expanded with soluble
light-activated enzymes, photocontrol of protein-protein interactions,
and cryptochromes that mediate light-induced protein oligomerization
(Rost et al., 2017). The group of soluble light-activated enzymes in-
cludes NIRW-photoactivated cyclases that bind flavin adenine dinu-
cleotide (FAD) and engineered light-activated PDEs that use biliverdin
as a chromophore, both permitting optogenetic control of cyclic nu-
cleotide signaling. This way, optogenetic modulation of cyclic nucleo-
tide signaling pathways can be achieved with high spatial and temporal
resolution, and as previously mentioned, without the need for and in-
terference of fiber optic cables.
Currently, we have arrived at the point in time where we, through
the use of genetic models, can obtain regional specificity and isoform/
subtype selectivity, linking cyclic nucleotide function to specific
memory types and processes. As such, these novel genetic approaches
provide excellent means to study the neurobiology of learning and
memory, and map the function of cyclic nucleotide signaling pathways
with great spatial and temporal resolution. Nevertheless, from a clinical
perspective, it is interesting to note how expression levels of the dif-
ferent cyclic nucleotide and their effector molecules change during
aging, suboptimal memory formation, and pathological conditions
(Kelly, 2018a). To this end, the novel gene CRISPR-Cas9 gene editing
technique, seems particularly suited. Using this technique, existing
genes can be removed and/or new ones can be added (Cong et al., 2013;
Hsu et al., 2014). If we can establish which particular splice variants
show increased or decreased expression in the human brain during the
course of a disease, CRISPR-Cas9 can be used to overexpress or delete
this specific splice variant in a region-specific manner in order to model
a particular type of pathology or to gain insight into the contribution of
the gene and its product during physiological conditions. In a similar
fashion, CRISPR-Cas9 can be used to validate the therapeutic potential
of specific target genes minimizing off-target effects. This way, CRISPR-
Cas9 gene editing provides a potential next step in the development of
genetic approaches to modulate hippocampal cyclic nucleotide sig-
naling cascades (Soto-Velasquez et al., 2018). In conclusion, using op-
tical biosensors along with a variety of genetic manipulations, including
chemogenetics, optogenetics, and CRISPR/Cas9 gene editing, we have
the means to study the function of cyclic nucleotides and their effectors
during both physiological and pathological neuroplasticity and memory
formation without spatiotemporal limitations (Humeau and Choquet,
2019).
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